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Exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) during pregnancy is of 
particular concern as it interrupts fetal growth and development. While susceptibility to 
many toxicants often varies among individuals due to genetic differences, current studies 
of the teratogenic effects of dioxin do not account for inter-individual variability when 
evaluating exposure risks.  Our study aims to evaluate the effects of dioxin exposure on 
pregnant females and fetal development in genetically diverse mice to determine how 
genetic background impacts susceptibility. We developed an in vivo study with a panel of 
mice that collectively mimic a heterogeneous human population. In this study, pregnant 
female mice from 16 diverse mouse strains are exposed to one of three doses of dioxin 
(0, 1, 100 ng/kg/day) for a period of 10 days following mating. At E10.5 (post-mating) mice 
are euthanized and embryos dissected. To determine effects of dioxin at different doses, 
non-cancerous pregnancy-related and cardiogenic endpoints were assessed. We found 
that genetic background influences response variation in both a strain- and endpoint-
dependent manner. This data emphasizes the importance of accounting for genetic 
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I.1 Risk Assessment of Environmental Toxicants 
I.1.1 Introduction 
 
For many years, federal and state government agencies, including U.S. Environmental 
Protection Agency (US EPA), have used risk assessment as the primary tool in 
addressing the concerns of various hazardous exposures(Abt, Rodricks, Levy, Zeise, & 
Burke, 2010). This process is formally involved in “planning risk assessment and ensuring 
thoroughness consistent with decision-making”(Abt et al., 2010). Human risk assessment 
guidelines generally consist of four essential steps: (1) hazard identification, (2) dose-
response assessment, (3) exposure assessment, and (4) risk characterization(Clewell, 
2005; Health, 1983) (Figure 1-1). 
 
 
















I.1.2 Hazard Identification 
 
The goal of hazard identification is to identify chemical substances that pose a threat to 
the overall well-being to the general population. During this step, researchers must first 
identify the toxic compound and where the primary exposure occurs(Gundert-Remy & 
Sonich-Mullin, 2002). It must then be determined which individuals within the general 
population that experience adverse effects and how they are exposed. With this 
information, scientist move forward to the exposure and dose response assessments. 
 
I.1.3 Dose Response & Exposure Assessment 
 
Dose-response assessment is key to quantifying adverse exposure outcomes and the 
likelihood these outcomes occur at various exposure levels(Chiu & Slob, 2015). Recent 
advances in developing these guidelines help quantify response variability and 
uncertainties, however, results greatly differ among endpoints(Chiu & Slob, 2015). 
Toxicodynamics (the effects of toxic compounds in the body) and toxicokinetics (the 
biological absorption and distribution leading to toxicity) are key components of hazard 
analysis and are critical for determining the mode-of-action (MOA) of a specific 
toxicant(Gundert-Remy & Sonich-Mullin, 2002).  Starting with the active form of the toxic 
compound, this sequence of events leads to an observed response used to identify 
influential biological elements of dose-response(Clewell, 2005). The MOA serves as proof 
of a response threshold, signifying the existence of upstream biochemical 
responses(Crump, 2011). Response curves are generated primarily from laboratory 





2011). Linear curves do not have inherent thresholds and imply that toxic response is 
capable at all levels of exposure. Nonlinear curves utilize the MOA and uncertainties in 
response found in data to formulate inherent thresholds in the response curves. 
 
Exposure assessment, integrates both hazard identification and dose-response to 
measure the intensity, prevalence, distribution and reoccurrence of the target compound. 
The exposed community are assessed through health questionnaires and evaluations 
during exposure assessment, and the magnitude and frequency of the affected population 
are measured(Peters, Glass, Milne, Fritschi1, & consortium, 2014). Some individuals 
respond to chemical hazards more aggressively than others, and this increases the 
uncertainty in calculating a population response(Chiu & Slob, 2015). This data helps to 
identify the level of uncertainty associated with exposure risks and susceptibility to toxic 
chemical substances.  
 
I.1.4 Risk Characterization 
 
The final step, risk characterization, involves integration of the all the data collected from 
previous steps and the key findings and uncertainties are used in making final decisions 
on the overall risks associated with the toxic compound(Chiu & Slob, 2015). Risk 
characterization utilizes all the steps pf risk assessment to illustrate how the population 
will be affected by the target compound(Health, 1983; Jardine et al., 2003). With an array 
of risk assessment tools and data, the assessor makes decisions on how to assess the 





and determine the final decisions that are made concerning health policy and exposure 
prevention(Jardine et al., 2003; Walton, Dorne, & Renwick, 2001). 
 
If models lack sufficient knowledge of toxicity mechanisms, confounding health factors, 
or other toxicity-related factors, then risk estimations become largely contingent upon 
linearity within the low-dose (or “unobservable”) region of dose-response curves(Crump, 
1996; Gaylor, Kodell, Chen, & Krewski, 1999). Dose response curves are generated and 
analyzed further to predict safe exposure levels and response curves that lack thresholds 
undergo linear extrapolation. This method predicts the lowest risks for an adverse 
response, including negligible responses found within the low dose region(Gaylor et al., 
1999). 
 
I.1.5 Individual and Population Response 
 
Current risk assessment procedures analyze for a range of responses caused by 
chemical compounds. Response variability can be due to a wide array of extrinsic (i.e. 
diet, environmental co-factors, etc.) and intrinsic factors (i.e. genetic disposition, age, 
disease-state, etc.). Individual human health responses vary substantially in their 
response to toxic chemical compounds and this should be quantitatively integrated into 
risk decisions. Response due to genetic variability is assumed not to exist below the 
threshold, but there are highly susceptible backgrounds that can indeed fall below 
calculated response thresholds. Such factors account for small subgroups of the exposed 
population that are statistically insignificant when aggregated in current risk analyses. 





and threshold factors that do not account for individual variability. In such cases, those 
highly susceptible individuals tend to fall below the RfD (into the nonlinear low-dose 
range) and fall within the dose range that predicts no adverse outcomes. Uncertainty and 
genetic variability greatly impact all aspects of risk assessment but has not yet been fully 
recognized.  
 
The Hokkaido study, is just one example of the importance of understanding the effects 
of early low-dose environmental chemical exposures (i.e. dioxins, pesticides, 
methylmercury, etc.) on health outcomes of genetically susceptible subpopulations of 
children(Kishi et al., 2017). Other studies, much like the Chapaevsk (Russia) cohort study, 
have identified susceptible subpopulations (i.e. environmentally exposed adolescent 
boys) by identifying predictors of toxicity to chemical compounds, such as dioxins and 
dibenzofurans(Hauser, 2005). Regulatory agencies require more evidence to integrate 
these data into risk guidelines, but there is simply not enough information on how 
interindividual variability influences the risks of non-cancer effects(Bogen, 2016).  
 
Not all non-cancer outcomes have a threshold or non-linear response, due to background 
diseases and genetic influences found within the general population. For example, 
exposure levels that fall below the RfD are assumed “safe”, but lack further analysis or 
evidence(Chiu & Slob, 2015). In these cases, the RfD serves with limited function and 
can lead to misinterpretation of low-dose exposure risks. Emphasis on a unified approach 
for assessing safe exposure levels to cancerous and non-cancerous toxicants has long 





Crump, 2011; Gaylor et al., 1999). This approach relies on increased knowledge of toxic 
mechanisms and serves to address the uncertainties of human exposures within the low-
dose (unobservable) regions of dose-response curves(Crump, 1996). A unified 
framework will strengthen dose-response assessment by increasing step-wise precision 
and transparency of the process(Chiu & Slob, 2015). New methods of risk assessment 
are especially crucial for highly susceptible individuals within the population. In order to 
address all health concerns, we must utilize a technique that encompasses genetic 
variability as the driving force in understanding dose response. 
 
The human response to toxic chemicals varies in both magnitude of effects and 
susceptibility. A better understanding of how genetics influences individual response and 
susceptibility could link chemical assessment paradigms to more precise exposure risks 
calculations. With this knowledge a more accurate population-level approach can be used 
to predict toxicity in areas under current investigaton(Harrill & McAllister, 2017). 
  
I.1.6 Applications of Mouse Models for Risk Assessment 
 
The underlying goal of toxicology is to understand the toxic mechanisms of chemical 
compounds and the risks for adverse health effects. The overall decision-making process 
becomes increasingly difficult to accomplish when needed information from human data 
is ethically limited. One such study found human data on the endocrine disrupting effects 
of dioxin to be difficult to ascertain; so, the study utilized organ-on-chip technologies, 
along with murine models to assess the endocrine disrupting risks of dioxin exposure in 





of assessing risks with the knowledge that human exposure data cannot be generated at 
will and is only available through accidental exposures. Also, the limited human data 
available which can be complicated by co-exposures to other toxicants and uncertainties 
in determining the exposure dose.  
 
For many decades, mouse models have provided substantial contributions to 
understanding human exposures to chemicals ranging from pharmaceutical compound 
to environmental contaminant assessments(Grassman, Masten, Walker, & Lucier, 1998). 
The use of mice limit the dangers and ethical constructs faced when using humans in 
clinical studies(J, M, & M, 2014). Although the mouse genome does not exactly match 
that of a human, it is very easy to manipulate and offers broad variations in genetic 
background. Mice can also exhibit more rapid reproduction times compared to humans, 
which is beneficial when specific genetic background are needed. The mouse model can 
serve as a surrogate response for humans, in which both human and animal in vivo data 
are analogous(Grassman et al., 1998; Portier, 2001). 
 
The human genome varies widely across individuals; uniquely, the mouse genome can 
be manipulated to resemble more genetic variability than observed in the human 
population. A recent study conducted utilized a diverse mouse panel (known as the 
collaborative cross mice) to understand how genetic background influences response 
variation to a murine virus in understanding neurological diseases (i.e. Theiler’s murine 
encephalomyelitis virus)(Brinkmeyer-Langford et al., 2017). Another study uncovers 





toxicological relationship between perchloroethylene and trichloroacetate(Cichocki, 
2017). These data, and similar studies, utilize the advantages of using diverse mouse 
models as a resource for understanding human diseases and susceptibility.  
 
Mouse studies are uniquely suited to determine the effects of genetic variance on 
exposure to toxic chemicals, including 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, 
dioxin). Early studies revealed unique protein interactions with dioxin within mouse 
hepatocytes that are not observed in primate or human subjects and this suggested that 
mouse models would not be appropriate models for humans(Kimbrough). However, 
population-based mouse studies later took advantage of the diverse murine backgrounds 
to understand toxic responses of the genetically diverse human population as a whole. 
Those studies, such as response variations of the genotoxic components of murine 
benzene exposure or variations in the metabolism of butadiene, proved the relevance 
and benefits of using mouse populations in exposure studies that assess toxic 
environmental compounds(French et al., 2015; Hartman, 2017) . 
 
Mouse studies often encompass a single strain when analyzing human outcomes 
associated with toxicity and disease outcomes of chemical compounds. It is emphasized 
that use of multiple mouse strains yields greater benefits when attempting to translate 
results into human relevance(Mosedale, 2018; van der Schalie et al., 1999). However, 
due to budget and time constraints, research continues to use single-strain mouse 
outcomes with those of the general human population. This undoubtedly limits the 





Due to factors such as age, development, and genetic background, humans vary in their 
susceptibility to detrimental outcomes of dioxin exposure(Beck, Dross, & Mathar, 1994; 
DeVito, Birnbaum, Farland, & Gasiewicz, 1995; Orban, Stanley, Schwemberger, & 
Remmers, 1994; Ryan, Gasiewicz, & Brown, 1990). We utilize the animal model in order 
to better understand the mechanistic actions of dioxins and identify human biomarkers of 
suceptibility(Portier, 2001). With this approach, we improve upon previous science-based 
risk assessment models. 
 
I.2 Risk Assessment of TCDD and Related Compounds 
I.2.1 Introduction 
 
Dioxin and dioxin-like compounds are potent members of the polychlorinated dibenzo-p-
dioxin (PCDD) family of compounds. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) 
is the most potent member of the PCDD family. It is a highly toxic compound whose 
cellular effects are mediated by aryl hydrocarbon receptor (AHR)(Poland, Glover, & 
Kende, 1976). Upon activation, AHR upregulates enzymes that elicit a spectrum of 
downstream toxic responses(Bohonowych & Denison, 2007; Sorg, 2014). 
 
Chemists first discovered PCDD compounds throughout our ecosystem and identified 
them as byproducts of the synthesis of organochloride compounds(S. H. Safe, 1995). 
Their resistance to environmental degradation allows them to persist for long periods 
throughout the atmosphere, water, and soil(Hay, 1981; S. Safe, 1990). These ubiquitous 
environmental compounds cause a wide range of detrimental effects on human health 





found as complex mixtures with congeners and other halogenated compounds, such as 
PCBs and dibenzofurans(Dickson & Buzik, 1993).  The variation in toxicity of dioxin 
isomers, combined with the complexity of mixtures with related compounds, make 
assessing risks from exposure to these compounds very difficult(Barnes, 1991; Dickson 
& Buzik, 1993).  
 
I.2.2 Origins and Properties of TCDD 
 
PCDDs are commonly referred to as “dioxins,” signifying their overall structure consisting 
of two benzenes joined by two oxygen molecules.  Dioxins consists of 75 different 
congener molecules with different substitution of the chlorine atoms on the two aromatic 
rings(Dickson & Buzik, 1993). PCDDs are highly lipophilic with lipid solubility increasing 
with the number of chlorine substituents and the hydrophobicity of these compounds 
allows them to bioaccumulate in adipose tissue. Turkish studies revealed the mean WHO-
TEQ (World Health Organization toxic equivalents) human concentration of PCDDs of the 
general population to be around 9 pg/g fat(Cok et al., 2007).  The half-life of PCDDs in 
humans varies due to differences in body composition, in which dioxin persists longer in 
individuals with a higher fat to lean ratio (Table 1-1) (Byard, 1987; Orban et al., 1994; 






Table 1-1. Estimated Average Concentrations (pg/g) With Relative Standard Errors (RSEs,%) For Selected PCDDs And PCDFs From 
FY 1987 National Human Adipose Tissue Survey Composite Samples (Reprinted from Orban et al., 1994)*. Examples of variations in 
human PCDD congener levels in adipose tissue.  
 
TCDD is substituted with chlorines at positions 2, 3, 7, and 8; since this compound does 
not contain two adjacent unsubstituted carbon atoms the rate of metabolism is low and 
bioaccumulation in fatty tissue is high(Dickson & Buzik, 1993). TCDD is not directly used 
for industrial purposes but is a contaminant produced during synthesis of commercial 
chemical products, residential wood burning and forest fires, and these emissions lead to 
accumulation of TCDD and related compounds in the food chain(Czuczwa & Hites, 1984; 
Dickson & Buzik, 1993). 
 
 
                                               
* Reprinted from “Dioxins and dibenzofurans in adipose tissue of the general US population and selected subpopulations” by J.E. 
Orban, J.S. Stanley, J.G. Schwemberger, and J.C. Remmers, 1994. American Journal of Public Health, Volume 84, Issue 3, Pages 






I.2.3 AhR: Ligands and their Structural Diversity 
 
Early mouse exposure studies uncovered the mechanisms by which adaptive immune 
response minimized toxicity to ubiquitous environmental compounds. It was initially 
discovered that there was an increased expression of hepatic aryl hydrocarbon 
hydroxylase (Ahh) activity upon exposure to a number of toxic compounds, including 
benzo[a]pyrene (BaP) and 3-methylchlolanthrene (3-MC). This induction response was 
associated with enhanced cytochrome P450 (CYP)-dependent microsomal 
monooxygenase activity which, in turn, enhanced metabolism of BaP and related 
compounds(Schmidt & Bradfield, 1996). It was also reported that induction of Ahh activity 
was mouse strain-dependent and certain strains were designated as “responsive” and 
others as “non-responsive”. The discovery of dioxin’s high affinity for AHR later eliminated 
the idea of an “unresponsive strain,” as it induced a milder, yet toxic response(Poland & 
Glover, 1974),(Poland & Knutson, 1982b). Manipulation of the dominant responsive 
allele, Ahrb, and the recessive “unresponsive” allele, Ahrd, of inbred mouse strains led to 
the mechanistic model by which the Ahr encoded receptor proteins are essential to 
downstream induction of xenobiotic metabolizing enzymes, called cytochrome P450 
enzymes (Cyp450s)(Ema et al., 1994; Poland et al., 1976; Poland & Knutson, 1982b). It 
was later discovered that the underlying polymorphism for mouse Ahr responsiveness 
involved a missense mutation (alanine to valine) at position 375 in Ahrd allele (381 in 
human AHR) resulted in reduced affinity for dioxin(Ema et al., 1994).   
 
AHR is a transcription factor responsible for mediating many biological processes and 





mediates the expression of drug/xenobiotic metabolizing enzymes (DME/XME). Most of 
its toxic downstream effects, including tumor promotion, lymphoid involution, and 
porphyria, are activated upon binding halogenated aromatic hydrocarbons (HAHs) and 
polycyclic aromatic hydrocarbons (PAHs)(Poland & Knutson, 1982a; Schmidt & Bradfield, 
1996). Previous researchers have consistently shown HAH ligands to yield the highest 
AHR-dependent toxic responses, and this is due in part to the persistent occupation of 
the receptor by these ligands. Many other compounds, including health-promoting 
flavonoids, pharmaceuticals, and microbial metabolites activate AhR-mediated 
responses, but not the toxic responses(Bock Karl & Köhle, 2009; Budinsky et al., 2014).   
 
Within the cell, the inactive form AHR exists as a protein complex consisting of heat shock 
protein 90 (HSP 90), and other proteins(Sorg, 2014). Once activated upon ligand binding, 
AHR forms another protein complex with aryl hydrocarbon receptor nuclear transport 
(ARNT) protein. This complex then translocates into the nucleus, where it stimulates 
transcription of downstream toxic molecules, by binding cis-acting dioxin or xenobiotic 
response elements (DRE/XRE) in target gene promoters. 
 
Through ligand activation, AHR functions within the metabolic, reproductive, and immune 
systems. Many AHR ligands activate their own metabolism and excretion upon binding, 
but some compounds can lead to the formation of DNA and protein adducts(Josyula et 
al., 2000; Nerurkar et al., 1996; Xu, Li, & Kong, 2005). Those ligands commonly include 
Halogenated aromatic hydrocarbons (HAHs) polyhalogenated aromatic hydrocarbons 





2007; Budinsky et al., 2014). HAHs and PAHs induce CYPs once bound to AhR, but 
HAHs are not readily metabolized and are mostly classified as toxic AhR ligands. PAHs 
are readily metabolized and are known to form active metabolites. These metabolites can 
interact with DNA, forming adducts, that may result in downstream effects, such as 
initiation of cancer. Other AhR ligands (i.e. flavonoids, some pharmaceuticals, synthetic 
metabolites, and tryptophan metabolites) induce CYPs on a tissue-specific basis. These 
ligands, unlike HAHs or PAHs, may or induce or modulate biological pathways that are 
not necessarily toxic, but often beneficial. For example, the pharmaceutical drug, 
omeprazole, follows a non-genotoxic Ahr-dependent pathway that does not allow nuclear 
translocation of AhR. Through the activation of Jun-N-terminal kinase (JNK) and other 
downstream genes have shown to be beneficial in inhibiting cell migration and invasion 
of Panc1 in pancreatic cancer when using omeprazole(Jin, 2018). 
 
I.2.4 AhR: Genomic Pathways Include CYP Inductions 
 
When bound to HSP90, AHR is inactive and unable to bind ARNT. Within the cytosol 
several chaperone proteins bind and maintain the inactive form of AHR(Sorg, 2014). This 
latent AHR complex incudes HSP90, Hepatitis-B virus X-associated protein 2 (XAP2), 
and prostaglandin E synthase 3 (p23)(Schmidt & Bradfield, 1996). XAP2 protects the 
inactive AHR from ubiquitination and degradation; and p23 is involved in the maturation, 
stabilization, and translocation of the AHR complex. These proteins are necessary for 
normal functioning of AHR activity, but much of the underlying mechanisms of p23 and 
XAP are still unknown(Schmidt & Bradfield, 1996; Sorg, 2014; Stockinger, Di Meglio, 





HSP90 and ARNT both exclusively interact with the bHLH and PAS domains of AHR. An 
AHR ligand, such as TCDD, enters the cell and binds AHR. The bound AHR is activated 
and releases its latent chaperone protein complex (Figure 1-3). ARNT then 
heterodimerizes with AHR and may stimulate the release of HSP90 and other proteins. 
The activated AHR-ARNT complex translocates into the nucleus and interacts with DNA, 
by binding to xenobiotic/drug response elements (XRE or DRE); which are contained 
within the promoter region of target genes(Schmidt & Bradfield, 1996).  This interaction 
upregulates the transcription of Phase I and Phase II metabolizing enzymes (i.e. 
cytochrome P450 oxidative enzymes and UDP-glucuronosyltransferases, respectively). 
AHR signaling is subsequently down-regulated by the aryl hydrocarbon repressor protein 
(AHRR) and by ligand-induced proteasome-dependent degradation of the 
receptor(Beischlag, Luis Morales, Hollingshead, & Perdew, 2008; Nebert Dw Fau - 
Robinson, Robinson Jr Fau - Niwa, Niwa A Fau - Kumaki, Kumaki K Fau - Poland, & 
Poland, 1975). 
 

















Cytochrome P450s (CYP) are AHR-mediated microsomal hemoproteins responsible for 
the activation and detoxification of many drugs and toxic compounds. TCDD-induced 
CYP1 enzymes commonly include CYP1A1, CYP1B1, and CYP1A2. The level of 
activation depends on the AHR allele and ligand bound.  
 
I.2.5 AhR: Non-Genomic Pathways 
 
The AHR also mediates effects independent of gene activation, and this has also been 
observed for many other intercellular receptors including the estrogen receptor and other 
nuclear receptors. These effects can be explained through AhR-ligand-dependent 
activation of a non-genomic pathway that do not require ANRT(Dong & Matsumura, 
2008). For example, the rapid (~30 min.) increase in intracellular Ca2+ after dioxin 
exposure cannot be explained by genomic pathways, but through signal transduction 
activity of AHR(Nebert, Puga, & Vasiliou, 1993; Puga, Nebert, & Carrier, 1992). Another 
study reported immediate activation of ERK1 and ERK2 (within ~15 mins. of dioxin 
exposure) in human mammary epithelial cells and this was not accompanied by CYP1A1 
induction(Park, Mazina, Kitagawa, Wong, & Matsumura, 2004). Researchers speculated 








I.3 Adverse Health Impacts of TCDD 
I.3.1 Human Responses 
I.3.1.1 Accidental/Industrial Exposures 
 
Reports of acute high human exposures to TCDD have primarily occurred in chemical 
manufacturing and medical incineration plants(Calvert, Hornung, Sweeney, Fingerhut, & 
Halperin, 1992). Industrial incidents, like those seen in Seveso (Italy) and Nitro (West 
Virginia), and later through wartime exposures, laid the foundation for understanding the 
toxic effects of TCDD and related compounds. One of the earliest high dose industrial 
exposures, to TCDD were observed in a Monsanto Chemical Plant in 1949 and there 
were reports of chloracne, weight loss and fatigue in the exposed workers. There has 
also been concern regarding dioxin exposures that occurred during the Vietnam War 
(1962 – 1967). In 1976, a historical dioxin exposure occurred in Seveso, Italy, where a 
cloud of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) was released into the environment 
during the production of 2,4,5-trichlorophenol(CDC, 1988). Much of the cloud debris 
settled into nearby soil and wildlife (birds, rabbits, chickens, etc.) many of which were 
found dead. Preliminary human reports from this incidence indicated ingestion or dermal 
exposure led to chloracne (i.e. dermal lesions)(CDC, 1988; Kimbrough). According to the 
incident, when a chemical plant exploded, even those with acute exposures to dioxin 
developed symptoms(Assennato, Cervino, Emmett, Longo, & Merlo, 1989). Similar 
animal exposure models administered lethal doses of TCDD exhibited wasting syndrome 






I.3.1.2 Agent Orange 
 
The massive use of the defoliant Agent Orange during this war involved the largest 
amount of herbicide ever used within a country. US Military forces used this substance to 
defoliate in order to reveal enemy troops and destroy enemy crops. Veterans who were 
in contact with Agent Orange through handling, spraying and from environmental 
exposure exhibit increased prevalence of disorders in the thyroid gland, pituitary tumors, 
neurologic disorders, dermatitis (including chloracne) and liver damage, in both military 
personal and nearby residents(Assennato et al., 1989; Calvert et al., 1992; Tuyet-Hanh 
et al., 2015; Yi, Hong, Ohrr, & Yi, 2014). Many years after the war, Vietnam veterans had 
levels as high as of TCDD in adipose tissue(DeVito et al., 1995; Ryan et al., 1990). It was 
found that 2,3,7,8-tetrachloro-p-dioxin (TCDD) was found as a byproduct in the synthesis 
of 2,4,5-trichlorophenoxyacetic acid, the active ingredient of Agent Orange. The aftermath 
of Seveso and Vietnam exposures indicated that humans can tolerate around up to 
50,000ppt (ng/kg) of TCDD concentrated in lipid stores without exhibiting major toxic side 
effects, excluding chloracne(Kimbrough).  
 
I.3.1.3 Environmental Exposure 
 
Trace amounts of dioxin existed in the environment prior to the industrial revolution due 
to “natural” combustion processes (i.e. fossil fuels), however levels greatly increased with 
increased industrialization and chemical manufacturing. These emissions were complex 
mixtures of polychlorinated dibenzo-p-dioxins and dibenzofurans(Czuczwa & Hites, 1984; 





water, wildlife and plants. The levels of human exposure can be variable based, with 
people living in more industrialized countries having higher levels. The human population 
has a general background level between 1-2 ppt TCDD in serum lipids and humans 
acutely exposed through consumption of fatty foods, such as fish, milk and meat; and 
exposure to relatively small amounts through air and water (Kimbrough, 1991; Tuyet-
Hanh et al., 2015).  
 
Dioxin’s high affinity for lipids results in accumulation in adipocytes and leads to 
decreases in cellular metabolism(Orban et al., 1994; Ryan et al., 1990). Many effects of 
TCDD exposure resemble those of thyroid dysfunction, including weight loss, changes in 
hormone levels, and dermal anomalies, and altered immune fuction(S. Safe, 1990; S. H. 
Safe, 1995). Hepatic hypertrophy and hyperplasia is commonly due to prolonged AHR 
activation in most species and cytokine production is likely the cause of hepatotoxicity 
after prolong dioxin exposure in mice(Bock Karl & Köhle, 2009). 
 
In 1997, IARC classified TCDD as a Group 1 carcinogen, deeming it harmful to humans. 
The validity of this assessment has been long debated since it is primarily based on AHR 
mechanisms of carcinogenesis. Dioxin-induced carcinogenesis is thought to be through 
a pathway that upregulates Cyp1 enzymes, which correlates to the onset of tumor 
initiation and enhances promotion in cells that have already undergone initiation(Nebert, 
Dalton, Okey, & Gonzalez, 2004; Nebert et al., 1993). Upon substrate oxidation, CYP1 
enzymes form reactive intermediates that result in downstream DNA damage, adduct 





Mandel, 2003). Rodent hepatotoxicity studies revealed that dioxin’s downstream products 
inhibit apoptosis and causes tumor promotion(Luebeck, Buchmann, Stinchcombe, 
Moolgavkar, & Schwarz, 2000; Pitot, Goldsworthy, Campbell, & Poland, 1980; 
Stinchcombe, Buchmann, Bock, & Schwarz, 1995).  Genetic variation within the Ahr allele 
can also enhance dioxin-induced tumor promotion and progression, due to increased 
alterations in gene expression(Pitot et al., 1980).  
 
I.3.2 Toxicokinetic Properties 
 
TCDD is highly toxic to some animal and human species and has a wide inter- and 
intraspecies variation in response (Table  1-2). Over 1000-fold sensitivity differences have 
been reported in different rat strains that reveal these intraspecies difference in response 
in TCDD(Viluksela et al., 1996). Humans are acutely exposed to dioxin through toxic 
environmental mixtures. As the use of combustions processes increased in incineration 
and chemical production plants, so did the relevant background levels found in human 
tissues. The lipophilicity and stability of dioxin accounts for its biomagnification from 
reservoirs and sediment up the aquatic food chain into mammalian animals and humans.  
 
The human lifetime body and tissue (i.e. muscle, adipose, etc.) burdens of dioxin result 
from ingestion of contaminated foods, and in rare occasions through industrial accidents 
(Figure 1-3). Dioxin congeners are the major PCDDs and PCDFs found in fatty foods 
consumed by humans, even though a wide array of similar congeners is released in the 
environment. High dose exposures occur mostly through industrial accidents or long-term 





plant workers with inadequate protection from harmful compounds). Upon exposure, toxic 
effects are not elicited until the dioxin interacts with its target receptors (i.e. AhR) at 
sufficient concentrations and lengths of time.  
 
 
Table 1-2. Estimated Body Burdens of 2,3,7,8-TCDD/2,3,7,8-TCDD Equivalents (TEQ) Associated With Biochemical/Biological Effects 
In Experimental Animals And Humans (Reprinted from Ryan et al., 1990)*. Interspecies differences in TCDD effects based on dose, 
duration and body burden. 
 
Once inside the body, the half-life of dioxin and dioxin-like compounds is dependent on 
age and body fat content. The TCDD body burden of children is diluted faster than adults 
                                               
*Reprinted from “Human Body Burden of Polychlorinated Dibenzofurans Associated with Toxicity Based on the Yusho and Yucheng 
Incidents” by J.J. Ryan, T.A. Gasieicz, and J.F. Brown, Jr. 1990. Fundamental and Applied Toxicology, Volume 15, Issue 4, Pages 





due rapid growth, with smaller children having half-lives of about 4 months and adults 
having half-lives ranging around 7-10 years after exposure(Charnley & Kimbrough, 2006). 
The rates of eliminations decrease significantly with increased body fat burdens(Michalek 
& Tripathi, 1999). TCDD is shown to be primarily excreted through feces, seen in guinea 
pigs, rats and humans, with fecal lipids being a primary determinant of TCDD elimination 
rates(Rappe, 1992; Wendling, Orth, & Poiger, 1990).  
 
Fetal and infant metabolism of PCDDs is largely unknown but are proportionate to 
maternal concentrations(Kreuzer et al., 1997). These levels differ after birth depending 
on feeding method, with breast-fed infants having 0.38-4.1 ng/kg of TCDD and formula-
fed infants having 0.16-0.76 kg/ng of TCDD in adipose tissue(Kreuzer et al., 1997). As 
infants transition into adolescence, breast-fed infants show higher levels of TCDD levels 
in adipose tissue, but do not exceed normal background levels in adulthood (ranging from 
2-3 ng/kg in serum lipid)(Kreuzer et al., 1997). Until the age of 40 PCDD burdens have 
shown to range between 6-12 TEQ/kg serum lipid(Patterson, 2004).  
 
At low dioxin exposures, body fat percentage influences toxicokinetics, but at high 
exposures dioxin induces its own elimination(Edmond C, 2005). Dioxin is assumed to be 
at equilibrium across human organs and tissues, with a dose-dependent elimination half-
life of 5 to 10 years(Kreuzer et al., 1997). The rate of elimination significantly decreases 
as age and body fat percentage increases(Edmond C, 2005; Michalek & Tripathi, 1999).  





and elimination of dioxins and similar compounds, but much is unknown of any effective 
pharmacotherapy useful in decreasing the effects of exposure. 
 
Figure 1-3. Toxicokinetic Model Based On Hysiological Parameters For The Description Of Lifetime Burden Of The Human Organism 
With TCDD (2,3,7,8-Tetrachlorodibenzo-P-Dioxin) Model Contains Physiological Parameters, Food Intake, TCDD Elimination By 
Metabolism, And Its Fecal Excretion As Age Dependent Variables(Reprinted from Kreuzer et al., 1997)*. 
 
I.4 Effects of In Utero Exposure to TCDD 
 
Although much is known about potential effects of dioxin in the environment, more is still 
to be uncovered about effects on mammalian embryonic systems or differential effects 
across individual backgrounds. The effect of genetics on response to embryonic exposure 
to dioxin is of importance because toxicant exposures are thought to cause several 
pregnancy complications.  Dioxin action is mediated by AHR, which is present throughout 
female reproductive tissues and is involved in reproduction and development. If the AhR 
                                               
* Reprinted from “2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime 
body burden by TCDD with special emphasis on its uptake by nutrition” by P.E. Kreuzer, G.A. Csanady, C. Baur, W. Kessler, O. 






is inappropriately activated during pregnancy this may lead to developmental defects that 
are permanent and maybe persist through adulthood. These defects have been 
extensively characterized through mouse and zebrafish study and include skeletal 
malformations, restricted growth, neural defects, cardiovascular dysfunction and post-
natal lethality(Carney, Prasch, Heideman, & Peterson, 2006; Couture, Abbott, & 
Birnbaum, 1990; Kimmel, 1996).  
 
Consequently, dioxin exposure during pregnancy is of concern since it heightens the risk 
of fetal malformations, which can be incompatible with life, like the severe skeletal 
malformations of the skull and body seen during the aftermath of the Vietnam War. 
Although animal studies have shown that high exposure contributes to birth defects, 
human clinical data generated over the last few decades have only speculated that dioxin-
induced toxicity as an underlying cause of some birth defects. Recently, combined human 
and animal data have shown correlations between increased dioxin exposure and the 
gradual increase in the occurrence of birth defects.  
 
I.5 Applications of Genetically Diverse Mouse Models for Risk Assessment 
 
The use of diverse mouse models in studying dioxin-induced birth defects will provide 
important new insights on the clinical relevancy of effects of this compound on the 
genetically diverse human population. The National Research Council (NRC) have 
addressed concerns of how interindividual variability of the human population effect 
epidemiological studies and the utility of using genetically diverse animal models to fill 





Genetic variability is an important factor when assessing human exposures to 
environmental contaminants and can contribute to individual susceptibility or resistance 
to adverse exposure outcomes. Both intrinsic and extrinsic factors, such as age, genetic 
predisposition, nutrition, and exposure level, all determine the degree to which exposure 
response may vary(Zeise, 2013). Since risk assessment inherently involves individual 
variations of response, the current methodology must be redesigned to incorporate 
response variation found within the population to yield more accurate exposure 
assessments. When calculating exposure levels and effects in current risk assessment 
protocols uncertainties exist and are standardized through calculated response 
thresholds(U. S. E. P. A. U. EPA), 2014). These response thresholds do not accurately 
depict the response of a genetically diverse human population. 
 
Due to the ethical limitations of human models in toxicant assessments, we use 
experimental models capable of characterizing relevant sensitivities and effects found 
within human populations. Classical risk assessment models utilize traditional rodent 
models in testing toxicity, but these rodent strains lack genetic diversity due to fixed 
genomes. These isolated gene pools allow researchers to easily reproduce data, while 
reducing variations in results. Historical reasoning for their use is the ability to compare 
data from commonly used rodent strains across a variety of chemical exposure studies 
(Harrill & McAllister, 2017). Recent studies have exposed that the major drawback of 
single-strain studies is that rodent strains of different genetic backgrounds may vary in 
sensitivity to the adverse health effects associated with the studied toxic compound. For 





nephrotoxic outcomes of acetaminophen and trichlorethylene, have shown that some 
mouse strains have found to be resistant while others show increased sensitivity (Harrill 
AH, 2009; Yoo HS, 2015). 
 
Population-based rodent studies reflect the genetic diversity found within the genetically 
diverse human population. It allows researchers to investigate the variety of toxic 
responses, including, reproductive and developmental toxicities, nephrotoxicity, and 
hepatotoxicity, at the population level. They are also key in identifying genetic risk factors 
that influence susceptibility and various disease states. In risk assessment, diverse 
mouse populations allow scientists to better understand how to quantitatively assess 
interindividual variability in the toxicokinetics of toxic chemical compounds. These 
populations highlight the incorporation of highly susceptible individuals into overall data 
analysis, which is otherwise nonexistent in single-strain studies.  With this research, we 
hope to highlight the usefulness of population based rodent populations when predicting 
human hazards to toxic chemicals. Furthermore, this research will aid in the integration 












II PEANUT BUTTER AS AN ALTERNATIVE DOSE DELIVERY METHOD TO 
PREVENT OROGASTRIC GAVAGE-INDUCED STRESS IN MOUSE 
TERATOGENICITY STUDIES
 
II.1  Introduction 
 
Orogastric gavage is a frequently used route of drug and toxicant administration for 
exposure studies. In this procedure, a gastric feeding needle is inserted through the oral 
cavity to the esophagus for direct delivery into the stomach(Balcombe, Barnard, & 
Sandusky, 2004). However, this method has been associated with stress and 
physiological changes, such as altered hormone levels, esophageal damage, weight loss, 
increased blood pressure and altered adrenal gland size and function in rodents(Arantes-
Rodrigues et al., 2012; Balcombe et al., 2004; Brown, Dinger, & Levine, 2000; 
Dobrakovova & Jurcovicova, 1984; Murgas, Czako, & Dobrakovova, 1974). Procedure-
induced stress can impede study measurements and results(Walker et al., 2012). This is 
of great concern when animal data are used in evaluating potential human health 
outcomes and exposure limits since stress can directly alter behavior, immune response, 
development, and reproduction(Brown et al., 2000; Nicolaides, Kyratzi, 
Lamprokostopoulou, Chrousos, & Charmandari, 2015; Stratakis, Gold, & Chrousos, 
1995; Ziejewski et al., 2012). 
 
An alternative oral administration through diet can be effective and less stressful on 
rodents(Overk, Borgia, & Mufson, 2011; Walker et al., 2012). Recent studies have shown 





diet via a treat method(Kapetanovic et al., 2006). An ideal cost-efficient alternative to dose 
administration would be to incorporate common foods, such as peanut butter or honey, 
as vehicle(Kuster et al., 2012). With the use of peanut butter (PB), mice are able to self-
administer compounds under study. This delivery method is a more realistic model of 
exposure for assessing how animal exposure data translates into human exposure 
settings(de Meijer, Le, Meisel, & Puder, 2010; Kapetanovic et al., 2006).  
 
Animal models are especially useful when evaluating teratogen exposures, as human 
data are almost always lacking. Evaluating the teratogenic effects of environmental 
compounds on humans during pregnancy is unethical, so the mouse model serves as a 
surrogate. However, due to increased susceptibility and physiological demands of 
pregnancy, studies requiring repetitive orogastric gavage can induce unacceptably high 
levels of procedure-associated stress that can complicate interpretation of experimental 
results(Balcombe et al., 2004).  
 
To avoid added stress-induced physiological changes caused by orogastric gavage 
during pregnancy, we describe the use of peanut butter for self-administration in mice as 
a novel vehicle for dose administration. In our study, we utilize dioxin, an endocrine-
disrupting compound, as a model compound for teratogen exposure. The primary 
hormones used to evaluate experimental stress are glucocorticoids, a class of steroid 
hormones which include cortisol/corticosterone(Brown et al., 2000; Dobrakovova & 
Jurcovicova, 1984; Gonzales et al., 2014). Prenatal influx of these hormones has shown 





Dong, Wang, Cao, & Chen, 2014). We examined serum corticosterone levels, weight and 
reproductive endpoints to measure stress response of orogastric delivery versus self-
administration.  
 
Toxicologists have also become increasingly concerned with the genetic interactions of 
xenobiotics(Festing, 2001), which led to the growing field of toxicogenetics, in which 
human clinical relevance of animal data is improved through incorporation of genetic 
variability into animal studies. However, genetic heterogeneity of exposed human 
populations has rarely been replicated in animal pregnancy-associated exposure studies. 
Here we evaluated the impact of genetic heterogeneity on orogastric delivery during 
pregnancy using two different inbred mouse strains. 
 
II.2 Materials and Methods 
II.2.1 Animals 
 
All animals were handled according to Texas A&M University’s Institutional Animal Care 
and Use Committee (IACUC). Animals were obtained at 6-8 weeks of age from The 
Jackson Laboratory (Bar Harbor, ME). Mice were housed as mating trios in ventilated 
cages on 12-hour light/dark cycles under constant temperature and humidity and were 
provided mouse chow (4% Fat Mouse Chow Diet (2025), Rodent Diet Tekland 8064, 
Envigo, Madison, WI) ad libitum. Peanut butter habituation also occurred during trio 






Females were checked daily between 6-10am for compilation plugs. Plug-positive mice 
were individually housed and assigned to the following groups until day 10.5 of gestation 
(D10.5): dry gavage (DG), oil gavage (OG), high-dose dioxin gavage (HG), control peanut 
butter (CPB), high-dose dioxin peanut butter (HPB), or a control do not disturb (DND) 
group (Table 2-1). The final dose for all mice was administered between 6-8am via oral 
gavage to ensure each mouse received a full dose prior to euthanasia between 11am-
2pm. 
 
Group Administration Vehicle Treatment Dose Level 
(ng/kg/day TCDD) 
Dose Volume 
Oil Gavage (OG) Gavage Olive Oil Control 0 ng/kg/day 0.1 mL 
High Dose Gavage (HG) Gavage Olive Oil High Dose 100 ng/kg/day 0.1 mL 
Control Peanut Butter (CPB) Dietary Peanut Butter Control 0 ng/kg/day 3 g 
High Dose Peanut Butter (HPB) Dietary Peanut Butter High Dose 100 ng/kg/day 3 g 
Do Not Disturb (DND) None None Control (undisturbed) 0 ng/kg/day None 
Table 2-1. Experimental Design.. 
 
II.2.2 Dose Administration 
II.2.2.1 Peanut Butter (PB) preparation 
 
Dioxin doses were administered using 3g aliquots of PB based on initial weight of mice. 
Peanut butter was made by mixing 140g PB2® powder (Powdered Peanut Butter, Bell 
Plantation Inc., Tifton, GA) and 200 mL of ultrapure water (Milli-Q Advanced Water 
Purification System, MilliporeSigma, Darmstadt, Germany). Water was warmed and 
stirred on a hot plate until it reaching 40 ˚- 45 ˚C in a 500mL beaker. This recipe was 





protocol with dioxin. The required amount of dioxin for each dose group was then added 
along with a pinch (<1g) of PB2® powder and mixed for 5 minutes before the heat was 
turned off. PB2® was stirred in increments of 40g, 50g, and 50g, respectively. After mixing 
the final 50g, the mixture was vigorously stirred to ensure dioxin was distributed evenly. 
All aliquots were stored at 4 ˚C for no longer than 2 weeks. 
 
Once dioxin-laced PB protocols were finalized, samples were sent to the Dow Chemical 
Company to measure and confirm the accuracy of dioxin in each dose. PB was presented 
to mice in 35mm x 10mm cell cultures dishes for self-administration, but the use of 
polystyrene was a major concern because of the hydrophobic nature of dioxin. To test the 
amount of residual dioxin that bound to the plastic, dioxin-laced PB was stored in the 
dishes for the maximum 2 weeks, emptied, and the dishes sent to DOW. Insignificant 
trace amounts were found on each dish, indicating that the storage conditions did not 
result in dosage errors.   
 
II.2.2.2 PB Administration 
 
Mice assigned to PB dosing groups were trained by giving 3g of control PB per cage three 
times a week to ensure the entire PB dose was consumed. Once in trio-matings, mice 
assigned to the PB groups were then given 3g of control PB per cage daily. 
 
PB aliquots were gently placed into disposable cages to avoid disruption and reduce the 





each mouse at the initial dose (D1). There were a total of six dosing groups categorized 
by different weight ranges (Table 2-2). 
 
Dioxin was administered in 3g aliquots of PB on 35mm x 10mm cell cultures dishes. Mice 
were given a daily dose through PB aliquots until D10, when last dose was administered 
via orogastric gavage.  
 
Group Weight (g) Average Weight (g) 
1 12g 10 
2 12.01 – 17g 15 
3 17.01 – 22g 20 
4 22.01 – 27g 25 
5 27.01 – 32g 30 
6 ≥32.01g  35 
Table 2-2. Dioxin Peanut Butter Dose Category. 
 
II.2.3 Body Condition, Composition and Weights 
 
Bodily conditions were observed daily for signs of illness and stress. We monitored for 
hunched spines, scrunched coats, and any other signs that seemed unhealthy or out of 
the ordinary. Maternal body weights were recorded at gestation day one (D1) (initial dose) 
and D10.5 (euthanasia). Body weight and composition were measured on D1 and D10.5. 
Body composition was performed using an EchoMRI-100HTM Body Composition Analyzer 
(EchoMRI LLC, Houston TX). Both weights and body composition results were reported 






II.2.4 Serum Corticosterone (CORT) Levels 
 
Blood samples were collected from each mouse immediately after euthanasia on D10.5 
via cardiac puncture. Serum was collected using micro tubes containing gel with clotting 
activator (SARSTEDT; Order No. 41.1378.005). CORT levels were then measured by 
ELISA kit according to manufacturer’s protocol (Cayman Chemical - Product 501320, Ann 
Arbor, MI). The assay range for CORT was 8.2-5,000 pg/mL, with an R2 coefficient ³ 
0.990. 
 
II.2.5 Reproductive outcome analyses 
 
II.2.5.1 Implantation sites 
 
The implantation sites on D10.5 were visibly identified as circular gestational sacs (about 
5mm) found within the uterus(Mu, Slevin, Qu, McCormick, & Adamson, 2008). The uterus 
was further dissected to assess embryonic viability of each implantation site. Resorption 
sites or any other abnormality present were recorded. Embryos were further isolated to 
assign approximate developmental stage using The Atlas of Mouse Development Edition 








II.2.5.2 Ovarian fat analysis 
 
After blood collection, both ovaries, including surrounding ovarian fat, were collected and 
weighed. Ovaries underwent additional analysis for anomalies and size differences. 
Tissues were flash-frozen and stored at -80°C for analyses. 
 
II.2.6 Statistical Analysis 
 
Statistical analyses were performed using JMP Pro 12 (Cary, NC) statistical software and 
graphs were generated with GraphPad Prism 8 (San Diego, CA) software. One-way 
analysis of variance (ANOVA) tests were conducted on corticosterone levels, change in 
body weight, change in percentage of fat and lean weights, total implantation sites, and 
ovarian fat weight. For pregnancy rate, the experimental units used were female mice 
pregnant at the time of euthanasia at D10.5 and data were tested for independence by 
the chi-squared test. The data collected from pregnant mice within PB and gavage dose 
groups was compared to undisturbed pregnant control mice (DND) within each strain. 
Data was then compared across PB and gavage dose groups. If F static showed 
significance, the Dunnet’s t-test for pair-wise comparisons was used for each dosing 







II.3.1 Effect of orogastric gavage on pregnancy is dependent on genetic background 
 
We recorded the number of plug-positive mice and pregnancies found at D10.5 following 
continuous daily dosing from copulation to euthanasia. As shown in Table 2-3, 
129S1/SvlmJ mice have a lower rate of pregnancy than C57BL/6J mice across all doses. 
Both strains showed a decrease in the rate of pregnancy, but 129SvlmJ mice have shown 
to have a much larger decrease in pregnancies during oral gavage administration. 
Pregnant 129S1/SvlmJ mice administered oil gavage (OG) yielded no pregnancies at 
euthanasia (D10.5, n=6). The average difference in pregnancies between PB and gavage 
administration in this strain is much higher than those seen in C57BL/6J mice (Table 2-
3).  Our results also show that C57BL/6J mice have a small decrease in pregnancies with 
gavage administration compared to PB administration. Although there is a significant 
difference in the rate of pregnancy for 129S1/SvlmJ undisturbed mice (DND) to both 
administration methods, peanut butter administration yields higher rates of successful 
pregnancies than oral gavage. There were no pregnancies in 129S1/SvlmJ mice 
administered OG so this group was excluded from all figures. Overall, our results suggest 
that oral gavage negatively affects pregnancy rates. 
 
Table 2-3. Total Plug-Positive Mice And Successful Pregnancies Of 129S1/Svlmj And C57BL/6J Mice. After trio matings were set-up, 
mice were plug checked every morning. Plugs signified mating occurred overnight and were treated as potential pregnancies.  
 
Strain 
DND  CPB  HPB  DG  OG  HG 
na Preg.b Rate(%)c 
 
na Preg.b Rate(%)c 
 
na Preg.b Rate(%)c 
 
na Preg.b Rate(%)c 
 
na Preg.b Rate(%)c 
 
na Preg.b Rate(%)c 
129S1/SvlmJ 19 12 63*  34 14 41  14 5 36  12 2 17  6 0 0  12 2 17 
C57BL/6J 18 14 78  24 17 71  16 12 75  16 12 75  11 4 36  13 7 54 
a n represents the total number of copulations plugs (i.e. plug-positive mice). 
b Total number of mice pregnant at euthanasia (gestation day 10.5). 
c (Total number of pregnant mice at euthanasia)/(Total number of copulation plugs). 






II.3.2 Orogastric gavage increases serum CORT levels in 129S1/SvlmJ mice 
 
By examining the number of implantation sites within the uteri at D10.5, we were able to 
show that stress induced by dose administration methods had no effect on mean 
implantations in both 129S1/SvlmJ and C57BL/6J mouse strains (Figure 2-1). However, 
we did observe a decreasing trend in mean implantation sites in 129S1/SvlmJ mice that 
were administered dioxin PB. When comparing this finding to the same dioxin gavage 
dose (HG), HPB has a larger negative effect on implantation in 129S1/SvlmJ mice. 
Therefore, this effect suggests that teratogens, such as dioxin, administered through diet 
(PB) possibly have an increased delivery of dose. Due to genetic variation, C57BL/6J and 
129S1/SvlmJ mice have significantly different responses to administration methods. 
 
To further investigate whether oral gavage or peanut butter administration affected 
baseline stress levels, we analyzed the maternal physiological response to dosing 
conditions by measuring serum corticosterone (CORT) levels at D10.5. Serum CORT 
levels have no significant differences across all dose administration groups compared to 
the control group in C57BL/6J mice. On the contrary, an adverse outcome was observed 
in 129S1/SvlmJ dose administration groups. Mice administered oral gavage (dry gavage 
and high dose oil gavage) had significant increases in CORT levels, whereas the use of 
PB has no effect on CORT levels. 
 
During early morning administration, mice administered oral gavage were hunched and 
resistant when handled, further indicating gavage-induced stress. The lack of 





stress and oil addition as vehicle has some detrimental effects on pregnancy outcome. 
HG administration in 129S1/SvlmJ has a very large significant difference in mean CORT 
levels, compared to the controls, which implies underlying interactions between dioxin 
and CORT.  
 
II.3.3 Impacts of Oral gavage on Body Weight and Composition 
 
Mean body weight at the initial dose was not significantly different from the mean body 
weight at euthanasia between groups that received PB or gavage in both 129S1/SvlmJ 
and C57BL/6J pregnant mice compared to the control groups (Figure 2-2A). Oppositely, 
129S1/SvlmJ mice that received gavage administration and were not pregnant at D10.5 
showed significant differences in mean body weight at initial dose and euthanasia 
compared to control group (Figure 2-2B). C57BL/6J non-pregnant mice showed weight 
loss although not statistically significant, with the sole exception of OG administration 
being significantly different from both the control and CPB administration groups (Figure 
2-2B). 
 
Since we were able to detect differences in weight depending on administration method, 
we further analyzed body composition in both strains to evaluate changes in fat or lean 
mass at euthanasia in pregnant mice. We observed a significant difference in fat body 
mass in 129S1/SvlmJ mice when administered high dose gavage (HG) between initial 
dose and euthanasia compared to controls (Figure 2-2C). We also detected a significant 
change in lean body mass between initial dose and euthanasia in 129S1/SvlmJ mice 





retrieved in overall mean fat and lean body mass across all administration groups in 
C57BL/6J pregnant mice (Figure 2-2C and 2-2D). 
 
We looked into ovarian fat weight to understand genetic \background correlates with 
previous knowledge of dioxins interference with ovarian function and fertility. There was 
no significance in mean ovarian fat weight in all administration groups in 129S1/SvlmJ 
pregnant mice. On the contrary, C57BL/6J pregnant mice showed a significant increase 
in ovarian fat weight mean when administered CPB and HPB, respectively, compared to 
controls (Figure 2-3). The same effect was also detectable when administered HG 




Previous investigators have extensively focused on the post-natal effects of maternally 
imposed stress in mouse animal studies. These studies have reported that offspring show 
various stress-induced abnormalities in development, such as growth retardation, 
craniofacial defects and adverse behavioral patterns(Lee et al., 2008; Liu et al., 2014). 
However, few studies have focused on the effects of oral dose administration on 
pregnancy outcomes, such as implantation rates, when evaluating endocrine disruptive 
actions of compounds in pharmacological and toxicological studies. 
 
Developmental and reproductive animal studies are often used to assess the effects of 
environmental contaminants on human pregnancies and embryogenesis. Oral gavage is 





reported to impose stress and increase mortality rates(Stratakis & Chrousos, 1995). 
Although much data has been generated on gavage-induced stress, none of these 
studies address how these affects confound reproductive and developmental data 
generated from past pharmaceutical and toxicological exposure studies.  
 
In this study, we showed strain-dependent effects of oral gavage administration compared 
to dietary administration. The use of pregnancy as an overall endpoint was difficult to 
quantify as it depends on whether the animals will mate. Pregnant females were used to 
assess the effects of route administration on fecundity rates, body compositions, weight 
changes, and hormonal responses. 129S1/SvlmJ mice had lower fecundity rates when 
administered oral gavage, making calculating statistical significance of results difficult. 
Alternatively, the fecundity rates of C57BL/6J mice had no significant differences when 
administered oral gavage compared to controls and pregnant mice administered peanut 
butter (PB).  
 
The mouse model is very efficient in assessing environmental exposures to harmful 
toxicants, but these studies often use one strain to generate results. When assessing 
human risks to environmental exposures, the heterogeneity of the human population must 
also be considered in order to more accurately identify genomic biomarkers of 
exposure(Harrill, Ross, Gatti, Threadgill, & Rusyn, 2009). Unfortunately, the animal model 
is limited in its ability to translate into relevant clinical data. However, collecting data from 





therefore enhances our ability to uncover clinical relevancy(Festing, 2001; Harrill et al., 
2009). 
 
In our study, we addressed how genetic background plays a pivotal role in the stress 
response to administration route during pregnancy. In addition, we evaluated how these 
effects impact results generated from common environmental exposure studies, such as 
in vivo dioxin exposure. In order to mimic the heterogeneity found within the human 
population, the use of multiple mouse strains is necessary and more representative when 
translated into human data. As shown in our results, neither of the strains utilized showed 
similar data or trends. The overall response was significantly different between strains.  
 
The effects of administration method on fecundity were shown to be strain-dependent. 
This effect was not noticeable in the mean differences in weight, between D1 and 
euthanasia, of pregnant mice in both strains. The effects of administration and dioxin 
exposure were shown to be more significant in the weights of non-pregnant mice (i.e. 
mice that had no uterine implantations at euthanasia) than pregnant mice compared to 
their controls. During pregnancy weight gain is expected; which yields mean weight 
changes in pregnant mice to be negligible. With these expected weight changes, we are 
unable to determine whether the pregnant state yields protection against the effects of 
administration route on weight compared to the non-pregnant state. We also found the 
results of non-pregnant exposed mice to be beneficial to future pharmaceutical and 






129S1/SvlmJ non-pregnant mice administered oral gavage showed a significant weight 
loss. The reduction in weight was even more significant in both OG and HG administration 
when compared to DG. This implies that the olive oil vehicle, combined with the oral 
gavage needle, induces more stress determining weight loss in 129S1/SvlmJ mice. 
Therefore, we speculate that a less viscous vehicle could potentially reduce stress 
administration-induced in this particular strain. Mean weight changes in non-pregnant 
C57BL/6J mice administered OG were significantly different from the non-pregnant 
controls and CPB administration. In this strain, delivery method plays a pivotal role in 
accuracy of results and has the potential to confound data. 
 
Dioxins are known to have an effect on female fertility. One aspect is by compromising 
ovarian function and altering endocrine hormone levels involved in fertility and 
reproduction(O et al., 2011). Lower ovarian weights and follicular phase disruption has 
been shown to correlate with acute dioxin exposure in rodents(BK et al., 2001). We 
measured the change in ovarian fat weight (which includes ovaries) to analyze how this 
knowledge correlates with genetic variability. Although there were no significant 
differences in 129S1/SvlmJ mice, opposite results than what is shown in previous 
research were shown in C57BL/6J mice. The increase in C57BL/6J ovarian weight, when 
administered the peanut treat method, could possibly be due to decreased stress of using 
the peanut butter method. On the other hand, the C57BL/6J high dose gavage group 
implies the lipophilicity of peanut butter and/or dioxin could be attributing to the increased 






We also measured CORT levels to evaluate stress levels. In response to external 
stressors, the anterior pituitary is stimulated to release corticotropin (ACTH). This 
stimulation causes downstream effects that results in the release of glucocorticoids 
(cortisol/corticosterone)(Nicolaides et al., 2015; Stratakis & Chrousos, 1995). Responses 
to these molecules have been implicated to disrupt homeostasis, which detrimentally 
affects the immune response, growth and development, and reproduction(Stratakis & 
Chrousos, 1995; Stratakis et al., 1995).  
 
Proper function of the immune response and hypothalamic-pituitary-adrenal axis is crucial 
in maintaining homeostatic balance of normal pregnancies and fetal development(Mu et 
al., 2008; Stratakis & Chrousos, 1995). Animal stress response induces HPA axis 
function, which leads to increased production of glucocorticoids(Nicolaides et al., 2015; 
Stratakis & Chrousos, 1995). Hence, CORT, a glucocorticoid produced in mice, and 
cortisol (in humans) are typically used as hormonal indicators of stress. It has been shown 
that increased prenatal levels of corticosterone play a key role in the formation of cleft 
pallet in offspring, implantation rates, decreased birth weights, and pre-term deliveries 
(Fawcett et al., 1996; Liu et al., 2014; Ziejewski et al., 2012). 
 
In our study, we obtained blood samples from animals at D10.5 via cardiac puncture at 
necropsy; we then measured serum corticosterone levels of each animal. C57BL/6J mice 
had no significant differences in CORT levels across all dosing groups. On the other hand, 
CORT responses in 129S1/SvlmJ were significantly different suggesting that genetic 





all had significant increases in CORT levels. These levels increased from DG to HG 
administration compared to controls. The use of a gavage needle alone has shown to be 
the cause of increased stress in 129S1/SvlmJ mice compared to controls. Unfortunately, 
we are unable to determine whether adding the olive oil vehicle alone causes increased 
stress, due to fecundity rates OG administration. We speculate that the presence of the 
oil, either with or without the compound, has an even more negative effect on stress of 
129S1SvlmJ mice administered gavage. 
 
Our results, along with previous studies, establishes key principles in understanding how 
the mouse model is affected by stress and how these effects decrease accuracy of 
measured outcomes(de Meijer et al., 2010; Gonzales et al., 2014; Kapetanovic et al., 
2006; Kuster et al., 2012). The use of peanut butter as an alternative method of oral 
administration demonstrates increased efficacy of drug exposure in sensitive mouse 
models, including environmental exposure studies(Walker et al., 2012; Wheeler, Eppolito, 
Smith, Huff, & Smith, 2007). Many toxicological and pharmacological studies use diet and 
oral gavage interchangeably as means of dose administration. Our study has shown that 
these two methods should not be assumed to yield identical results. Dietary 
administration is preferred, as it yields a reduced stressed response in some strains, but 








Figure 2-1. Mean Implantation Sites And Corticosterone Levels Of Pregnant Mice Compared To Controls (DND). (A) The number of 
implantation sites found at euthanasia was recorded for each administration group within both strains. Dose administration method 
had no effect on mean implantations found with uteri compared to controls within each strain. (B) Blood serum was also collected and 
serum corticosterone levels were measured via ELISA. Strain-dependent effects of administration methods on serum CORT levels 


































































































Figure 2-2. Percent Weight And Body Composition Changes. (A) Mean change in body weight (g) of pregnant mice between gestation 
day 1 and euthanasia compared to pregnant controls. (B) Mean change in body weight (g) of non-pregnant mice between gestation 
day 1 (D1) and euthanasia compared to non-pregnant controls. (C) Mean change in percentage of fat weight of pregnant mice 
compared to pregnant control mice. The change in weight is a measure of the difference between fat weight at D1 and D10.5. (D) 
Mean change in percentage of lean weight of pregnant mice compared to pregnant control mice. The change in weight is a measure 
































































































































































































Figure 2-3. Ovarian Fat Weight In Pregnant Mice. Mean ovarian fat weight (g) in pregnant mice at euthanasia on gestation D10.5 





















































































































































III A POPULATION-BASED APPROACH TO ASSESS THE TERATOGENIC 





Environmental toxicants, such as dioxin, have become of increasing concern to pregnant 
women. Dioxin activity is mediated by the aryl hydrocarbon receptor (AHR), which is 
present throughout female reproductive tissues and is involved in reproduction and 
development. AHR is encoded by four different alleles in mice: Ahrb-1, Ahrb-2, Ahrb-3 and 
Ahrd. The mouse strains having different alleles manifest different dose response 
relationships for TCDD toxicity. Mice that harbor Ahrd allele are considered to be much 
“less responsive” or “nonresponsive” to dioxin exposure, and more genetically identical 
to the human AHR allele(Schmidt & Bradfield, 1996; Sorg, 2014; Thomas, Penn, Holden, 
Bradfield, & Rank, 2002). During pregnancy inappropriate AHR activation can lead to 
developmental defects that persist through adulthood(Sorg, 2014; Wang, Wang, Wu, Li, 
& Lu, 2013). Due to this sensitive developmental window, human studies are unsuitable 
for investigating dose-response relationships.  
 
Ahr in murine models has been found to not only play a vital role in xenobiotic metabolism, 
but also in cellular regulation and developmental processes(Nebert et al., 1993; Sorg, 
2014). AHR can contribute to altered gene expression and the onset of disease 





such as dioxin, have the ability to alter AHR activity and related developmental programs 
that result in the onset of diseases, including congenital heart defects. Consequently, 
dioxin exposure is a particular concern during pregnancy as it heightens the risk of fetal 
malformations that can be incompatible with life. Acute, high dose exposures to dioxin 
during the Agent Orange use in the Vietnam War and the chemical plant Explosions in 
Seveso, Italy have been linked to decreased growth, structural and functional 
malformations, and fetal death(Eskenazi et al., 2003; Schecter et al., 1995; Warner et al., 
2007). Although these early studies have phenotypically showed the link between high 
exposure dioxin and birth defects, human accidental exposure data generated have only 
speculated dioxin-induced toxicity as the underlying cause.  
 
Dioxin’s widespread environmental distribution is a major health concern among pregnant 
women(Couture et al., 1990; Seo et al., 1995). Early murine embryo/fetal toxicity studies 
revealed hydronephrosis, cleft palate, thymic atrophy, fetal mortality, and decreased birth 
weight in response to dioxin exposure(Couture et al., 1990). Maternal data reveal early 
signs of toxicity correlating with decreased weight. Although the effects of dioxin have 
been investigated during pregnancy in mice, those studies have evaluated dioxin toxicity 
in a single-mouse strain(Abbott, Held, et al., 1999; Dragin, Dalton, Miller, Shertzer, & 
Nebert, 2006; Takagi, Matsui, Yamashita, Ohmori, & Yasuda, 2000). C57BL/6J mice are 
a commonly used mouse strain, but their genetic makeup does not represent the genetic 
diversity found within the general human population. Early exposure studies referred to a 





effects, such as cleft palate, became a great concern among pregnant mothers in high 
exposure areas. 
 
Researchers later became more interested with the differences in inter-species 
responses, which showed significant differences in developmental responses(Dorne, 
2004, 2010; Reichard et al., 2016). But this data is significant in assessing environmental 
exposure and tells us little on how these effects may vary between individuals of the same 
species. Genetic variation likely underlies differential susceptibility to adverse outcomes 
induced by dioxin exposure(Dorne, 2010). Therefore, the current study utilizes a genetic 





Mouse strains were chosen from Mouse Phenome Diversity (MPD) Panel and were 
selected due to their favorable pathological and physiological comparisons to the level 
and types of response variations found in the human population (C57BL/6J, A/J, 
NOD/ShiLt, NZO/HiLt, and 129S1/SvlmJ). Additional inbred strains were chosen to have 
significantly high fecundity rates (CBA/J, C3HeB/FeJ, DBA/1J, FVB/NJ, and BALB/cJ) 
(Figure 3-1). The MPD Panel strains were supplemented with strains from the 
Collaborative Cross and BXD recombinant inbred panels that also have high fecundity 
(CC019/TauUNC, CC041/TauUNC, BXD40/TyJ, BXD91/2RwwJ, and BXD100/RwwJ). 





Madison, WI) ad libitum. Mice were set-up in trio matings (2 females and 1 male) and 
checked daily for copulation plugs to establish embryonic timing; noon on the day that 
plugs were detected was assigned embryonic day (E) 1. All procedures were approved 
by and performed according to Texas A&M University IACUC guidelines.  
 
III.2.2 TCDD Preparation 
 
Dioxin doses were administered using 3g aliquots of peanut butter (PB) based on initial 
weight of mice. Peanut butter was made by mixing 140g PB2® powder (Powdered Peanut 
Butter, Bell Plantation Inc., Tifton, GA) and 200 mL of ultrapure water (Milli-Q Advanced 
Water Purification System, MilliporeSigma, Darmstadt, Germany). Water was stirred and 
warmed up to 40 ˚- 45 ˚C on a hot plate in a 500mL beaker. This recipe was repeated 
approximately 20 times to ensure accuracy of dosing when creating the final protocol with 
dioxin. The required amount of dioxin for each dose group was then added along with a 
pinch (<1g) of PB2® powder and mixed for 5 minutes before the heat was turned off. 
PB2® was stirred in increments of 40g, 50g, and 50g, respectively. After mixing the final 
50g, the mixture was vigorously stirred to ensure dioxin was distributed evenly. All 
aliquots were stored at 4 ˚C for no longer than 2 weeks. 
 
III.2.3 TCDD Administration 
 
At 3 weeks of age, mice were habituated to eat a defined amount of PB, the vehicle for 





cage 3 times a week to ensure the entire PB dose was delivered. At 4-6 weeks of age, 
mice were placed in trio-matings as described above and assigned to a dose group. 
 
Dioxin was administered in 3g aliquots of PB. Mice were given their respective dose daily 
through PB aliquots until E10, when the final dose was administered via oral gavage 
(Figure 3-2).  The final dose was given via oral gavage to ensure the complete dose was 
administered and in the digestive tract prior to euthanasia, which followed later the same 
day. We exposed a total of 14 strains of pregnant female mice to increasing doses of 
TCDD (0 control, 1, 100 ng/kg body weight/day) for a period of 10 days following mating 
(Figure 3-2). Each female in the trio-matings was checked daily for the presence of a 
copulation plug. 
 
III.2.3.1 Sample Collection 
 
Prior to initial (E1) and final (E10) doses, mice were weighed and body compositions were 
assessed using magnetic resonance imaging (MRI). At day E10.5 mice were 
anesthetized with 1.25% Avertin (tribromoethanol; 0.018ml/gram of body weight 
category) for blood collection, then euthanized by cervical dislocation for organ and tissue 
collection. The gross anatomy of the uterus was observed and recorded, along with the 
number of implantation sites. Each uterus was further dissected to assess tissue viability 
of each implantation site. The uterus was further dissected under a microscope to remove 






III.2.3.2 Implantation Site Examination 
 
The implantation sites on E10.5 were visibly identified as circular gestational sacs (about 
5mm) within the uterus(Mu et al., 2008). The number of viable embryos, and number of 
resorption sites were recorded. Embryos were further isolated to analyze developmental 
stage. Embryo implantation and resorption sites were determined with the use of The 
Atlas of Mouse Development Edition 1 (Kaufmann, M.H., Elsevier Academic Press 1992). 
Developmental stages were determined by comparison to images provided in atlas. Half 
of the viable embryos recovered were stored in RNAlater (ThermoFisher Scientific) and 
the other half were fixed in formalin. 
 
III.2.4 Statistical Analysis 
  
Statistical analyses were performed using JMP Pro 12 (Cary, NC) statistical software and 
graphs were generated with GraphPad Prism 8 (San Diego, CA) software. One-way 
analysis of variance (ANOVA) tests were done on change in body weight, percentage of 
resorptions, and total implantation sites. If an F static showed significance, the Dunnet’s 
t-test for pair-wise comparisons was used for each dosing group. Data were presented at 








III.3.1 Effect of TCDD Exposure on Pregnancy Rates 
 
We initially examined the effects of dioxin exposure on successful pregnancy (or 
implantation). Doses were chosen based on low dose region of the previous dioxin 
exposure paradigm. We chose the low dose end to ensure we were better able to identify 
individual strains with high susceptibility. In mice we found a variation in fertility/pregnancy 
rates in response to dioxin. Some strains showed no overt signs of being affected by 
exposure, compared to controls. There is a slight, but not significant, gradual decrease in 
pregnancy rate when comparing across controls to high dose groups in BXD100/RwwJ, 
129S1/SvlmJ, and NZO/HiLtJ mouse strains (Table 3-1). But some mouse strains, 
including C57BL/6J, FVB/NJ, CC-19, and DBA/1J, have increasing trends in fertility when 
comparing controls to high dose groups. The effects of dioxin do not appear to be as 
significant on fertility at the low dose range.  
 
III.3.2 Effect of TCDD Exposure on Implantation Sites 
 
The result shown above suggested that dioxin exposure slightly decreases pregnancy 
rates in certain genetic backgrounds, so we examined its effects on the total number  of 
implantation sites found within pregnant mice. Results were grouped by Ahr allelic 
differences of each strain. Our results show mice are grouped based on strain Ahr allelic 
background, to evaluate the differences in previous mouse AHR allele data and current 





the uteri if mouse strains with the B2 AHR allele and one D allele strain (Figure 3-4). 
BALB/cJ mice showed a significant increase in mean implantation sights at the high dose, 
but not at the low dose compared to the control group. In contrast, C3HeB/FeJ and A/J 
mice administered the low dose (1 ng/kg/day) had a significant increase in mean 
implantation sites at the low dose, but not the high dose compared to the controls. 
NOD/ShiLtJ mice showed a very significant decrease in mean implantations at the low 
dose, but not at the high dose compared to the controls. These results suggest that when 
the effects of dioxin are compared across multiple genetic backgrounds of the same 
species, AHR allelic differences seems to have little to no significance in interpreting 
results. 
 
III.3.3 Effect of TCDD Exposure on Resorption Sites 
 
To account for inter-strain differences in mean number of implantation sites, we 
determined the intra-strain differences in the percentage of resorption sites at each dose 
of dioxin. There were no significant differences in the mean percentage of resorptions 
found within implantation sites, except for the 129S1/SvlmJ (SV) mice (Figure 3-3). At the 
high dose (100 ng/kg/day TCDD), 129S1/SvlmJ mice had a significant increase in the 
percentage of resorptions. Some strains including, NZO/HiLtJ, NOD/ShiLt, BXD40/TyJ, 
C3HEB/FeJ, A/J, and BXD100/RwwJ, showed an increasing trend in the percent of 
resorptions when comparing control groups to high dose groups, but there were no 






III.3.4 Effect of TCDD on Mean Changes in Weight During Pregnancy 
 
The previous results determined that endpoints related to pregnancy and fertility are 
strain-dependent, with some strains not experiencing certain effects to dioxin exposure. 
We then examined the change in maternal body weight between gestation days 1 (E1; 
copulation plug) and 10 (E10; euthanasia) to determine maternal effects of dioxin 
exposure during pregnancy. CBA/J mice showed a very significant decrease in weight at 
the high dose, but not the low dose compared to the controls. A/J mice dosed at the high 
dose had a significant increase in weight compared to the controls (Figure 3-5). On the 
other hand, BXD100/RwwJ mice given the low dose had a very significant decrease in 




Previous teratogenic studies do not address genetics as a major player in responses to 
environmental exposures(Churchill et al., 2004; Dorne, 2004). We have studied the 
effects of acute dioxin exposures on pregnancy and genetic susceptibility. Our results 
help to expand upon the current knowledge of the impacts genetics has on individual 
susceptibility. Each endpoint investigated in our study showed variation, in which no one 




To incorporate genetic background into dose response studies, we utilized 14 different 
inbred mouse strains to model genetic diversity. These strains varied in their response to 
dioxin through their differences in AHR alleles. There is considerable data suggesting 
AHR’s pivotal role in dioxin response, but comparable studies have not been assessed in 
multiple genetic backgrounds(Schmidt & Bradfield, 1996; Thomas et al., 2002). Mice have 
four variations of this allele: The B “responsive” allele (with 3 variations) and the D “non-
responsive” allele(Harper, Golas, & Okey, 1991; Nebert et al., 2004; Wang et al., 2013). 
According to our data, the Ahr allelic status is not the primary factor mediating dioxin-
induced pregnancy effects. 
Pregnancy was assessed by various endpoints that are widely accepted as fertility and 
pregnancy markers. Several studies have also linked dioxin to infertility in both the male 
and female reproductive systems(Couture et al., 1990; Eskenazi et al., 2010).  Pregnancy 
was initially assessed in this study with percentages of pregnancies, which is supported 
in multiple publications as an indicator of change in pregnancy rate or fertility(Aragon, 
Kopf, Campen, Huwe, & Walker, 2008; Couture et al., 1990; Eskenazi et al., 2010; H & 
R, 1981). We found that strains with genetic backgrounds comparable to C3HeB/FeJ are 
primarily unaffected by exposure to dioxin and dioxin-like compounds. Conversely, strains 
such as BXD100/RwwJ and NZO/HiLtJ experienced slightly higher detrimental effects of 
dioxin on pregnancy rate (or fertility) compared to control groups. Despite the obvious 
inter-strain differences in fertility, we found no significant differences in the relative rate of 





Implantation is consistently used as markers of successful pregnancies in various studies, 
but many do not further assess the implantation sites for embryonic viability(F. B, 2000; 
L. B et al., 2006; M et al., 2004). We then examined the percent of viable embryos found 
within each implantation site.  We found variation in response that did not have similarities 
to other endpoints. Significant differences in resorption percentages were only found in 
129S1/SvlmJ mice, which showed a significant increase at the high dose compared to 
the controls. This made it evident that 129S1/SvlmJ mice are more susceptible to 
increased resorptions (or decreased embryo viability). Other strains were not significantly 
affected by dioxin at this endpoint, but some showed to have more detrimental effects at 
different endpoints. 
 
There are several reports evaluating the relevance of weight loss and dioxin exposure in 
both pregnancy and nonpregnancy related exposure studies(Couture et al., 1990; E, W, 
M, S, & C, 2014; Kimbrough; Schecter et al., 2006). Our weight related results have 
shown to be consistent with our previous data, as interstrain differences affect the 
variation in response to each endpoint a few strains made it evident that comparable 
backgrounds may have the same level of susceptibility to weight changes in response to 
dioxin exposure. Weight change could also possible be an indication of embryo viability 
or successful implantations. 
 
Our results showed that individual response depends on both genetic background and 
the endpoint being measured. Each endpoint had different dynamics in response within 





background on pregnancy-related consequence in a range of physiological and physical 
responses to dioxin response.  
 
In conclusion, we mimicked human heterogeneity by using multiple genetically-diverse 
mouse strains in order to investigate the how genetic background contributes to variation 
in responses to dioxin. Our results showed that dioxin exposure resulted in variation in 
pregnancy implantation rates and resorptions, as well as maternal body weight, varied 
across mouse strains. demonstrated that population variability should be considered 
when determining dose response to toxicants found through the environment. This model 
is an effective tool in modeling susceptibility and adverse health effects in risk 
assessment. It is also important in assessing sensitive experimental model such as 
pregnancy. This information may be considered later when producing medical 
interventions or treatments for susceptible individuals living in areas where exposure to 
dioxin and dioxin-like compounds is prevalent. This data also prevalent when choosing 












III.5 Figures and Tables 
 
 
Figure 3-1. Inbred Mouse Family Tree Showing The Genetic Relatedness Of Some Of The Strains Used In This Study (Circled). 
(Adapted from Petkov, P. M., et al. 2004)*  
                                               
* Adapted from “An Efficient SNP System for Mouse Genome Scanning and Elucidating Strain Relationships” by P.M. Petkov, et al, 








• Daily check for copulation plug
• No dose administered
E1
• Presence of a copulation plug
• Body composition measured (MRI)
• Initial TCDD dose administerd through peanut butter (PB)
E2 - E9
• TCDD dose administered through PB
E10
• Body compostion measured (MRI)
• Final TCDD dose administered through oral gastric gavage
E10.5
• Necropsy
Figure 3-2. Experimental Timeline. 
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Table 3-1. Total Positive Plugs And Pregnancies. Total plug-positive mice and successful pregnancies of all mouse strains. After trio-
matings were set-up, mice were plug checked every morning. Plugs signified mating occurred overnight and were treated as potential 
pregnancies. 
Strain 














(B1) 8 8 1 10 8 0.8 10 7 0.7 
C57BL/6J (B1) 16 11 0.69 10 10 1 16 12 0.75 
A/J (B2) 16 13 0.81 12 8 0.67 12 9 0.75 
BALB/cJ (B2) 17 9 0.53 15 7 0.47 11 6 0.55 
C3HeB/FeJ (B2) 10 10 1 10 10 1 8 8 1 
CBA/J (B2) 8 8 1 7 7 1 12 11 0.96 
FVB/NJ (B2) 18 12 0.67 12 9 0.75 9 8 0.89 
129S1/SvlmJ (D) 14 7 0.5 11 4 0.36 14 5 0.36 
BXD40/TyJ (D) 7 6 0.86 10 9 0.9 9 7 0.78 
CC-19 (D) 10 7 0.7 5 4 0.8 7 6 0.86 
DBA/1J (D) 13 10 0.77 7 6 0.86 12 10 0.83 
NOD/ShiLtJ (D) 8 8 1 9 9 1 9 8 0.89 
NZO/HiLtJ (D) 8 6 0.75 8 5 0.63 12 7 0.58 
62 
Figure 3-3. Percent Embryos Resorbed Within Implantation Sites Compared To Controls Of The Same Strain. Average percent of 
non-viable or necrotic tissue found within implantation sites in uterus at gestation day 10.5 (euthanasia) compared to pregnant control 






Figure 3-4. Mean Implantation Sites Of Pregnant Mice Compared To Controls Across All Strains. The number of implantation sites 
found within the uteruses at euthanasia was recorded for each administration group within each strain compared to pregnant control 







Figure 3-5. Mean Overall Body Weight Change Compared To Controls. Mean change in body weight (g) of pregnant mice between 














IV RT-PCR QUANTIFICATION OF CARDIOGENIC TRANSCRIPTION FACTORS IN 
DEVELOPING EMBRYO HEARTS OF DIVERSE MOUSE POPULATIONS 
EXPOSED TO DIOXIN 
IV.1 Introduction 
  
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) is a potent, ubiquitous environmental 
toxicant that effects reproduction and development in mammals and fish, which poses 
risks to human health.  Embryos and fetuses of aquatic and mammalian species have 
shown to be more susceptible to dioxin toxicity. This is of great concern as maternal body 
burdens are transferred to their offspring during pregnancy and through 
breastfeeding(Furst, 2006; Schecter, Kassis, & Papke, 1998). Developmental toxicity of 
dioxin and dioxin-like compounds became evident through children born to mothers who 
reported decreased birth weights, respiratory distress, and hyperpigmentation of skin.  
 
Cardiogenesis is especially sensitive to toxicity of environmental toxicants, including 
dioxin, as is the longest functioning organ in the developing fetus. Chick embryo and 
zebrafish studies have revealed that exposure to dioxin and dioxin-like compounds leads 
to decreased heart size, valve malformation, and arterial dysfunction, similar to those 
seen in congenital heart defects of children born to mothers living in areas of high dioxin 
exposure(Walker & Catron, 2000). 
 
Although molecular and histological aspect of dioxin-induced cardiotoxicity have been 





hepatocytes, developmental studies have not been performed in depth in mammals. Early 
histological changes in the heart were mostly deleterious, which resulted in impaired 
function(Antkiewicz, 2005; Mehta, Peterson, & Heideman, 2008). Factors contributing to 
cardiotoxicity include master regulators and transcription factors associated with normal 
development and function of the target organ being studied. Understanding how exposure 
alters the expression of these genes can uncover the underlying fundamental 
mechanisms of dioxin cardiotoxicity.  
 
Early signaling cascades involved in cardiogenesis are conserved across species. These 
highly conserved genetic programs are controlled by gene regulatory networks(Davidson 
& Erwin, 2006). Cardiac master regulators that control the early stages of cardiogenesis, 
such as GATA4, NKX2-5, AND TBX5, can be detected at the transcription level. Upon 
exposure to dioxin, early cascades alter the expression levels of downstream networks 
leading ultimately leading to the overall dysfunction of the heart later in development. 
Differences in gene expression levels of these factors can vary among individuals and 
can also play a vital role in determining overall cardiotoxicity. 
 
Dioxin-related toxicities have been described for several mammalian systems, including 
reproductive, endocrine, nervous, immune and skeletal systems(Yoshizawa, Heatherly, 
Malarkey, Walker, & Nyska, 2007). The mammalian cardiovascular system has been a 
known target for halogenated aromatic hydrocarbon (HAH) toxicity(Mohsenzadeh, 
Zanjani, & Karimi, 2018). Our previous dioxin exposure study examined the effects on 





were not sensitive enough to identify high individual susceptibility to dioxin toxicity. To 
investigate markers that are potentially more sensitive, we examined dioxin induced 
cardiotoxicity in mouse embryos and the expression of several transcription factors 
involved in cardiogenesis (Table 4-1). The genes chosen are well-known in the early 
stages in cardiogenesis and should be sensitive markers for response to in utero dioxin 





All experimental procedures and protocols for animal use and research were approved 
by IACUC at Texas A&M University. Inbred mice were obtained from The Jaxson 
Laboratory (Bar Harbor, Maine) and from the Collaborative Cross mouse resource at the 
University of North Carolina and bred in house. Mice were provided water and standard 
mouse chow (Rodent Diet Tekland 8064, Envigo, Madison, WI) ad libitum. Mice were set-
up in trio matings (2 females and 1 male) and checked daily for copulation plugs to 
establish embryonic timing; noon on the day that plugs were detected was assigned 
embryonic day (E) 1. Dioxin doses (beginning on E1) were administered using 3g aliquots 
of peanut butter (PB) based on initial weight of mice. Peanut butter was made by mixing 
140g PB2® powder (Powdered Peanut Butter, Bell Plantation Inc., Tifton, GA) and 200 
mL of ultrapure water (Milli-Q Advanced Water Purification System, MilliporeSigma, 






IV.2.2 Cardiac Tissue Collection 
 
At day E10.5 mice were euthanized by CO2 asphyxiation and cervical dislocation for 
organ and tissue collection. The uterus was removed and further dissected for removal 
of embryos. After embryo examination, cardiac tissue was further removed from E10.5 
embryos and stored in RNAlater (Sigma Aldrich). 
 
IV.2.3 RT-PCR Expression of Cardiogenic Markers 
IV.2.3.1 RNA Isolation 
 
Heart tissues were washed in TE Buffer prior to isolating RNA to reduce the interaction 
of RNAlater with isolation process. Washed tissues were then homogenized in 500mL of 
TriZOL Reagent (Invotrogen, Carlsbad, CA) with chrome-steel beads using a TissueLyser 
II (Qiagen). The optional chloroform extraction step was added to the manufacture’s 
protocol.  RNA was further isolated using the PureLink RNA Mini Kit (Invitrogen, Carlsbad, 
CA). The manufacturer’s instructions were followed with the optional PureLink DNase Set 





Conversion of 2µg RNA to cDNA was done using QuantiTect Reverse Transcription Kit 





assess the relative expression of Cyp1A1, Cyp1B1, Gata4, Hand1, Hand2, Mef2c, 
Nkx2.5, Pitx2, Tbx3, Tbx5, and Tbx20. RTPCR was performed using a LightCycler 96 
System (Roche, Basel, Switzerland). Expression was normalized to the geometric mean 
of Gapdh and b-Actin for the SYBR green-based analysis. The 2−∆∆CT method was used 
to calculate fold changes(Livak, 2001). 
 
IV.2.4 Statistical Analysis 
 
Statistical analyses were performed using JMP Pro 12 (Cary, NC) statistical software and 
graphs were generated with GraphPad Prism 8 (San Diego, CA) software. One-way 
analysis of variance (ANOVA) tests were conducted on change in relative gene 
expression of cardiac genes (Table 4-2). If F static showed significance, the Dunnet’s t-
test for pair-wise comparisons was used for each dosing group. Data were presented at 




After 10 consecutive days of dosing mice with 1 ng/kg and 100 ng/kg of dioxin, we 
quantified the relative expression of transcription factors and genes relevant to cardiac 
development. Our previous studies, focusing on the reproductive and developmental 
effects of dioxin exposure showed very little intrastrain statistical significance in response, 
but significant variations in interstrain responses. We then focused on observing the 





in utero dioxin exposure, specifically expression levels of genes involved in 
cardiogenesis. Heart data showed overall significant interstrain differences in cardiac 
gene expression and variations of significant interstrain differences in gene expression. 
Both data sets emphasize the influence genetic background has on response to acute 
dioxin exposures. However, the random distribution of significant relative gene expression 
across strains remains consistent with the random intrastrain significant differences seen 
in previous reproductive and developmental endpoints.  
 
IV.3.1 Interstrain Variability in Cardiac Gene Expression 
 
We evaluated gene expression for 11 transcription factors that are either involved in 
cardiogenesis or significant to dioxin exposure (Table 4-2). Relative gene expression 
values were measured in pooled embryo hearts from individual pregnant mice from our 
previous maternal studies and used to analyze changes in relative gene expression 
(Figure 4-1). All genes showed significant interstrain differences at both treatment levels. 
Intrastrain differences varied across genes and dose level. 
 
IV.3.2 Dioxin-Induced Changes in Cytochrome P450 (CYP) Gene Expression of Embryo 
Hearts 
 
Common cytochrome P450s (CYPs) expression levels were examined due their known 
induction in relation to acute dioxin exposures(Carney, Peterson, & Heideman, 2004; 





Cyp1a1 expression levels are seen in the 1ng/kg dose of dioxin compared to the controls, 
with mostly no significance seen at the 100 ng/kg dose. This could be a possible result of 
acclimation, in which fetal hearts become accustomed to exposure at the low dose but 
show no signs of toxicity at the high dose. Cyp1b1 expression has a higher instance of 
interstrain significance seen between the 100 ng/kg dose and the controls. There are 
fewer significant differences in Cyp1b1 expression compared to Cyp1a1. Some of the 
mouse strains, including BALB/cJ, BXD100, and CBA/J, showed no changes in CYP 
expression in response to dioxin exposure. This data shows that changes CYP 
expression are strain-dependent, and cannot solely determine dioxin toxicity. 
 
IV.3.3 Dioxin-Induced Changes Cardiac Gene Expression of Embryo Hearts 
 
Some mouse strains showed very few significant changes in response to dioxin exposure. 
Those strains, including CBA/J and NZO/HiLtJ, had very little significant differences in 
cardiac gene expression, but showed changes in PITX2 and TBX5 expression, which 
could possibly cause changes in fetal heart looping, chamber formation and septation in 
the mature hearts of embryos exposed to dioxin in utero. Although these changes are 
expected to be seen in the later stages of cardiogenesis, they could potentially but fatal 
to the mature heart. 
 
Acclimation is seen across several cardiac genes, mostly in A/J, BXD40, BXD100, and 
C3HeB/FeJ strains. These strains will mostly like exhibit early and late heart 





due to the significant changes in expression levels of key regulators of response (such as 
GATA4 and NKX2.5). Very few significant differences are seen at the 100 ng/kg dose, 
which yields them less sensitive to toxicity at high doses, with increased sensitivity to low 
doses. These strains could potentially represent individuals with high susceptibility to the 
cardiogenic effects of dioxin exposure. Overall, dioxin-induced toxicity is seen across 
cardiac genes in a strain- and gene-dependent manor. Individual strain susceptibility 
varies among the measured cardiac genes with no significant patterns or inherent 




It has long been known the effects of maternal dioxin exposure. Much of which has been 
revealed was through various accidental exposures including industrial explosions in 
Seveso, Italy and the massive herbicidal use of Agent Orange in the Vietnam war(CDC, 
1988; Eskenazi et al., 2003). These two incidents alone revealed downstream 
teratogenic, nephrotoxic and hepatoxic effects of those exposed. Recent studies continue 
to uncover the teratogenic effects those exposures have on breast milk, fetal death, and 
the overall development of the children exposed through maternal and environmental 
means.  
 
Much evidence has been revealed about the effects of dioxin-induced toxicity on 
cardiogenesis, including its fatal effects on fetal hearts, altered linear heart tube formation 





underlying genetic causes of these malformations, but proved the effectiveness of using 
a genetically diverse mouse population to identify high susceptibility to the toxic effects of 
in utero acute dioxin exposures. The significant intrastrain differences shown across the 
cardiac genes measured further exerted our claim in our maternal study that individual 
susceptibility is dependent on both the toxic dose and the endpoint being measured.  
 
The genetically diverse population of mice chosen for this study showed that some strains 
have higher chances of altered expression in some genes but not in others. For example, 
129/SvlmJ mice are more susceptible to expression changes of Pitx2 and Tbx20 at both 
the high and low dose of dioxin, but no effects in Hand1 expression at either dose. The 
opposite is seen in NZO/ShiLtJ mice, thus proving the importance of including genetic 
variation found in the population in toxic exposure studies. Other studies have 
incorporated the use of genetically diverse mouse populations to improve current risk 
assessment practices, discover biomarkers of toxicity to acetaminophen and to 
understand the genetic parameters of benzene toxicity(French et al., 2015; Harrill & 
McAllister, 2017; Harrill et al., 2009). The concept of these and related studies is that the 
use of genetically diverse mouse populations is more effective in identifying and 
understanding models of disease and susceptibility found within certain subpopulations. 
The use of single, common rodent strains lacks the genetic variation required in 
identifying key genetic elements of toxicity, thus can be ineffective when compared to 






Several aspects of our project may have improved the methods by which toxicogenomic 
exposures studies are conducted. We mimicked the diversity found within the general 
population with the use a diverse inbred mouse strains.  Those strains that showed 
significant changes in gene expression could serve as population-based biomarkers of 
response. The unique genetic backgrounds of each strain allow us to better define the 
intrinsic genetic factors involved in susceptibility to dioxin toxicity and similar compounds. 
With this knowledge, we have the potential to detect high susceptibility within the general 
population earlier during exposures to toxic chemical substances. This is especially 
beneficial to pregnant women and developing fetuses, as they are at high risk for 




The teratogenicity of acute, dioxin exposure is of great concern due to its negative 
outcomes and implications on fetal development. Understanding maternal endpoints 
alone are not significant enough to gain a full understanding of how genetic backgrounds 
impacts susceptibility and exposure response. Our study contributes to the understanding 
that susceptibly depends not only on genetic background, but also the endpoint being 
studied. We focused on cardiogenic markers in dioxin response, which identified potential 
strain-dependent genetic markers of toxicity. This data further emphasizes the importance 































































Table 4-1. Comparison Of Human And Mouse Stages Of Cardiogenesis And Genes Expressed. Chart of the primary structures, with 





















GENE NAME MAIN FUNCTION 
(CARDIOGENESIS) 
DESCRIPTION REFERENCES 
Cyp1A1 Cytochrome P450 1A1 Xenobiotic metabolism (i.e. 
dioxins) 
Biotransformation of endogenous and 
exogenous substances (i.e. toxins, drugs, 
etc.) 
(Abbott, 
Schmid, et al., 
1999; Bozina, 
2009; Carney 
et al., 2004; 
Nebert et al., 
2004) 
Cyp1B1 Cytochrome P450 1B1 Xenobiotic metabolism (i.e. 
dioxins) 
Biotransformation of endogenous and 
exogenous substances (i.e. toxins, drugs, 
etc.) 
(Bozina, 2009; 
Nebert et al., 
2004) 
Gata4 GATA Protein 4 (GATA 
Binding Factor 4) 
Early cardiogenic 
transcriptional regulator 
Expressed early in cardiac development 
and influences cardiac cell fate (i.e. 
cardiomyocyte differentiation); Key 
transcriptional regulator of cardiac genes; 




Valimaki et al., 
2017; Watt AJ, 
2004) 
Hand1 Hand Factor 1 Ventricle formation Left ventricle, pericardium and 




Hand2 Hand Factor 2 Ventricle formation Cardiac crescent, outflow tract, left and 






Enhancer Factor 2  
 
Cardiogenic transcriptional 
regulator; Linear heart tube 
formation 
Heart looping; Right ventricle 
formation/maturation; Vascular 
endothelial cell differentiation; Early 
marker of cardiac muscle cells 
(Edmondson, 
Lyons, Martin, 
& Olson, 1994; 










Cardiac crescent and 
linear heart tube formation; 
Heart looping 
Endocardium and myocardium formation; 
Cardiomyocyte differentiation; Key 
transcriptional regulator of cardiac genes; 
Initiation of cardiogenic cascades 
(Benson et al., 
1999; Lien et 
al., 1999; 
Lyons et al., 
1995) 
Pitx2 Pituitary Homeobox 
Transcription Factor 2 
Left-right heart signaling 
mediator 
Regulates left/right symmetry; Key in 
determination of heart looping; Regulates 








Tbx3 T-box Protein 3 Cardiac transcriptional 
enhancer; Regulate cell 
fate and proliferation 
Septation; Maturation of cardiac 
conduction system and cardiac outflow 
tract; Cardiac pacemaker gene program 
induction 
(Cai et al., 
2005; Mohan 
et al., 2018) 
Tbx5 T-box Protein 5 Cardiac transcriptional 
enhancer; Regulate cell 
fate and proliferation 
Septation; Atrium and ventricle formation; 
Mutations result in Holt-Oram syndrome  
(Bruneau et al., 
2001; Cai et 
al., 2005) 
Tbx20 T-box Protein 20 Cardiac transcriptional 
enhancer; Regulate cell 
fate and proliferation 
Early cardiac crescent signaling 
cascades; myocardium and endocardium 
development 
(Cai et al., 
2005) 
 
Table 4-2. Table Of Major Cardiogenic Factors. Chart of major functions and detailed descriptions of major genes/transcription factors 







Figure 4-1. Expression Of Cardiogenic Markers In Response To Dioxin Exposure Across A Diverse Mouse Population. Changes in 
relative expression levels of in (A) CYP1A1, (B) CYP1B1, (C) GATA4, (D) HAND1, (E) HAND2, (F) MEF2C, (G) NKX2.5, (H) PITX2, 







































































































































































































































































































































































































































































































































































































































































































































































































































When assessing environmental risks and depending on the chemical, either cancerous 
or noncancerous guidelines are followed(Calabrese & Baldwin, 2001; Calabrese, 
Shamoun, & Hanekamp, 2015). Cancerous guidelines, take on a more aggressive 
approach to dose-response, that results in linearization of the response curve with no 
safe level of exposure. With noncancerous guidelines, dose-response curves are 
believed to have inherent thresholds for a toxic response(Bogdanffy et al., 2001; Bogen, 
2016; Calabrese et al., 2015) Exposure levels below the threshold represent “safe” 
exposure levels in which the general population is expected not to experience adverse 
outcomes. These levels do not account for uncertainty factors that attribute to individual 
susceptibility and response variability. By omitting, highly susceptible individuals in the 
general human population are no considered during the decision-making stages of risk 
assessment.  
 
Dioxin is ideal for characterizing the utility of a unified approach to noncancerous and 
cancerous risk assessment guidelines. Unification of these guidelines can decrease the 
uncertainty found within the available human and animal exposure data, which generally 
does not include genetic background consideration in response to dioxin. The effects of 
dioxin have been long studied in both human and animal models, with many 
noncancerous effects having been uncovered. Animal models has shown that dioxin 





toxicity, and hepatoxicity(Cole et al., 2003).  With the use of its reproductive and 
developmental toxicity data, in combination with a model that considers genetic 
heterogeneity, we further expand upon current knowledge with how known effects vary in 
a heterogeneous population. Our studies help acknowledge sensitive genetic 
backgrounds found within “safe” exposure levels. 
 
Dioxin and dioxin-like compounds are stable, hydrophobic compounds found throughout 
the environment(Hay, 1981; Schecter et al., 2006). Humans are commonly exposed to 
these compounds primarily through contaminated poultry and dairy products(Charnley & 
Doull, 2005; Schecter et al., 1994), although acute, high dose exposures can occur 
through industrial accidents. Once exposed, dioxins are stored in adipose tissues due to 
their hydrophobicity(Byard, 1987).  Toxicity is mediated through interactions with the aryl 
hydrocarbon receptor (AHR), which elicits downstream toxic responses through genomic 
and non-genomic AhR interactions(Beischlag et al., 2008; Bock Karl & Köhle, 2009; 
Poland & Glover, 1974). AHR is expressed throughout the reproductive tract of females, 
which makes dioxin toxicity of heightened concern for reproduction and development. 
Confirming the sensitivity of these tissues, exposure to dioxin is known to result in various 
developmental malformations in animal studies, including cleft palate, fetal death, 
congenital heart defects, and decreased birth weight(Abbott & Birnbaum, 1991; Abbott, 
Held, et al., 1999; Aragon et al., 2008; Birnbaum, Weber, Harris, Lamb, & McKinney, 
1985; Carney et al., 2006; Dragin et al., 2006; Nebert et al., 2004). Our research utilizes 
the current knowledge of the reproductive effects of dioxin to investigate and understand 
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how genetic variability may alter susceptibly to reproductive and developmental dioxin 
toxicity. 
Human risk assessors have gaps in the available data that limits their ability to assess 
exposure risks across populations. Many factors can introduce inherent variability that 
increases uncertainty. Individual factors, such as age, gender, race, disease state, 
genetic predisposition, and body composition, are variables that can increase uncertainty 
when assessing population response variability to toxic compounds(Ashauer, 2010; Chiu, 
Okino, & Evans, 2009; Dorne & Renwick, 2005). The research reported in this dissertation 
helps to understand how uncertainty in dose response is generated by genetic variation, 
and the importance of including factors, like genetic variability, into risk assessment 
guidelines.  
Few research studies have used heterogeneous animal populations to model genetic 
variation found within the general human population(Dorne, 2010; Dorne, Walton, & 
Renwick, 2005; Smith, 1996; Walton et al., 2001). Animal models are more suitable for 
understanding toxicity and dose response to various compounds since they allow us to 
control for confounding variables, such as disease state, previous environmental 
exposures and genetic predisposition, that contribute to uncertainty in human data. 
Mouse models offers several advantages over other animal models. Mice have shorter 
generation times, produce large numbers of offspring, and are cost efficient, which allow 
them to facilitate large scale studies. The majority of the mouse genome and general 





that is important in understanding mechanistic causes of human disease, biological 
elements of toxicity, and the development of targeted genetic treatments. Our study 
utilizes the advantages of mouse models in understanding dioxin response at the 
population level. 
 
Although there are many advantages in using mouse models, there are also several 
disadvantages that can confound results. One of the major disadvantages is that animals 
can be easily stressed during experimental procedures. In fact, mice are typically exposed 
to chemical compounds through orogastric gavage. This method utilizes a gavage needle 
the allows a specified dose of a chosen compound to be directly administered into the 
stomach modeling oral exposure. To reduce the impact of stress of toxicity endpoints, we 
used the treat method as an alternative dose delivery and highlight the strain-dependent 
disadvantages of using orogastric gavage as mean of dose delivery during pregnancy 
exposure studies. 
 
Mice are especially unique for studies involving dioxins, as they have different Ahr alleles. 
They can have either the Ahrb allele, which is considered “more responsive” or the Ahrd 
allele, which is considered “less responsive” and more similar to human AHR(Harper et 
al., 1991).  With these additional allelic differences, mice are more suitable models for 
human dose response and understanding how genetic variability affects susceptibility. 
With reported differences in human AHR, mice with the Ahrb allele become useful in 





variability within the mouse population to better model human exposure risks associated 
with dioxin.  
 
Clinical research primarily focuses on the noncancerous effects as they relate to human 
outcomes during risk assessment(Bogen, 2016; Calabrese & Baldwin, 2001; Gaylor et 
al., 1999). Since noncancerous protocols follow the threshold approach of dose response, 
much is unknown about the effects of dioxin on highly susceptible individuals(Dorne et 
al., 2005; Walton et al., 2001). We show that even for noncancerous endpoints, 




In this dissertation, we examined how experimental design alters experimental results 
and how genetics influences adverse outcomes during hazardous chemical exposures. 
We examined a standard delivery method (orogastric gavage) and found unique 
interstrain differences in the stress imposed by orogastric gavage compared to the treat 
(peanut butter) method during pregnancy. While orogastric gavage can be an effective 
method in some mouse strains, other strains demonstrated varying responses to stress-
related conditions. As pregnancy is already known to be a sensitive endpoint, additional 
stressors can confound sensitive endpoints like pregnancy. Pregnant 129S1/SvlmJ mice 
had significantly higher serum corticosterone levels, a key marker of stress, following 10 
consecutive days of gavage administration compared to peanut butter treats. This 





experimental endpoints. In contrast, C57BL/6J mice were more resistant to external 
stress at all end-points and did not demonstrate an increased stress response in gavage 
vs treat delivery. The dioxin delivered through the peanut butter method induced an 
overall higher level of dioxin-induced adverse responses at most endpoints in 
129S2/SvlmJ mice than with orogastric gavage. The unwanted stress of gavage can 
hinder the full effect of exposure and results become difficult to interpret and less reliable 
for human risk assessments of similar environmental compounds. 
 
Previous research showed that there is an increase in the underlying stress of the animals 
when the orogastric method is used compared to diet or treat methods of dose 
administration(Arantes-Rodrigues et al., 2012; Balcombe et al., 2004; Brown et al., 2000; 
de Meijer et al., 2010). Alternative exposure methods have been suggested, such as the 
treat method, in which the chemical compound is combined with the treat. Although much 
has been uncovered on how the stress of experimental conditions impacts experimental 
results, there is no data addressing how genetic backgrounds influence responses to 
stressors. Our research confirmed that orogastric gavage causes gavage-induced stress 
on experimental animals, but in a strain-dependent manner, suggesting that genetics 
influences the impact of the delivery method.  Dose delivery-associated stress and 
genetic background interact in a way that alter the response data in some strains of mice.  
 
Knowing how individual susceptibility impacts dose-response curves, it should be 
included when calculating safe exposure levels during risk assessment of individuals 





effects of dioxin in the environment, much still needs to be discovered concerning its 
effects across individuals. Determining these effects will ultimately contribute to a better 
understanding of exposure risks during pregnancy and development.  
 
With the use of the treat method, we exposed a genetically diverse mouse population to 
dioxin in order to understand the interactions of genetic background and exposure 
response. We then found that effects of dioxin exposure during pregnancy is largely 
dependent on genetic background. We analyzed several pregnancy-related endpoints, 
such as pregnancy rate, implantation, resorption, and maternal weights. Each endpoint 
showed interstrain variation in response to dioxin. Some strains seemed to be more 
susceptible to low dose (1 ng/kg/day) than high dose (100 ng/kg/day), while other strains 
showed no susceptibility to dioxin exposure at all endpoints. The overall data suggest that 
genetic background contributes to individual susceptibility of dioxin-induced adverse 
health outcomes. 
 
Additionally, we expanded this study beyond reproduction phenotypes by examining 
embryonic development, specifically cardiogenesis, at the molecular level. Literature 
suggests that adverse cardiac effects will be cause by dioxin exposure, but do not assess 
how genetic background influences heart toxicity. The heart is one of the first major 
organs to form and function on its own, therefore it is exposed to toxic compounds for a 
longer time compared to other developing organs. Our data showed that using a 





susceptibility to early exposure of dioxin. With this data, we hope to achieve a more 




The use of a genetically diverse mouse population is useful in many studies used 
throughout risk assessment procedures and guidelines(Harrill & McAllister, 2017). 
Understanding how underlying doses of hazardous chemical compounds affect essential 
biological processes is key in exposure assessment. There is limited data on human 
assessment, which makes using population-based mouse models ideal for estimating 
internal toxic doses. Mouse data used in this way allows risk assessors to quantitatively 
address interindividual variability of toxic chemical exposures(Ashauer, 2010; Dorne et 
al., 2005; Harrill & McAllister, 2017). 
 
Our research investigated the effects of genetic background on response to dioxin 
exposure during pregnancy. This study broadens the scope of genetic background by 
utilizing 14 diverse mouse strains. These strains also included allelic differences in the 
Ahr gene, which are known to contribute to variation in dioxin-induced toxicity, allowing 
us to explore the effect of Ahr within a larger genomic context. This is significant in 
ensuring proper protocols and guidelines are being followed and protecting sensitive 
individuals within the exposed general population and hazardous occupational settings. 
Previous research suggests that diverse mouse populations, such as this one, can 
potentially redefine dose-response with more accurate concentration thresholds (i.e. 
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linearization of response curve) that can protect more people from adverse health effects 
of toxic chemical compounds. 
Population response variability found within mouse populations are similar to the variation 
seen within human populations of previous toxic exposure studies(Chiu et al., 2009). Our 
research showed that the interstrain differences determined the extent to which dioxin 
induced negative responses at certain endpoints. Single-strain studies have the potential 
to miss adverse outcomes seen in human subpopulations with higher exposure 
sensitivity. Our mouse population model provides a means by which genetically sensitive 
individuals can be detected and incorporated into risk analysis. Our results emphasize 
the benefits of being able to quantifying the distribution and extent of adverse health 
effects and define sensitive human subpopulations. In doing so, the mouse population 
model has the potential to redefine the dose response curve of noncancerous endpoints 
and guidelines. 
Our research is significant to the development of preventative mechanisms and treatment 
options of conditions that arise during pregnancy in response to toxicant exposure in 
humans. Upon development of these models, we expect advancements in assessing 
exposure risks and lessening the environmental burden of dioxin-related complications 
that affect millions of exposed pregnant mothers residing in highly contaminated areas in 
the US and around the globe. It also provides new insights on the role of genetics in 
response variance of individuals exposed to dioxin and similar contaminants. 
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V.4 Future Directions 
The main limitation of this study was the limited number of pregnant females due to low 
fecundity rates, which limited our statistical power. Mice mate at vastly different rates and 
do not guarantee mating will occur. These limitations can decrease the potential genetic 
variability of the mouse population, as strains with low reproductive performance are not 
usable. In efforts of resolving this problem, we chose mouse strains with medium to high 
fecundity rates.  
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